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ABSTRACT 
 
Chromosomal replication is an essential process in all life. This 
dissertation highlights regulatory roles for two critical protein complexes at the 
heart of the replication fork: 1) the sliding clamp, the major polymerase 
processivity factor, and 2) the sliding clamp loader, a spiral-shaped AAA+ 
ATPase, which loads the clamp onto DNA. 
 The clamp is a promiscuous binding protein that interacts with at least 100 
binding partners to orchestrate many processes on DNA, but spatiotemporal 
regulation of these binding interactions is unknown. Remarkably, a recent 
disease-causing mutant of the sliding clamp showed specific defects in DNA 
repair pathways. We aimed to use this mutant as a tool to understand the binding 
specificity of clamp interactions, and investigate the disease further. We solved 
three structures of the mutant, and biochemically showed perturbation of partner-
binding for some, but not all, ligands. Using a fission yeast model, we showed 
that mutant cells are sensitive to select DNA damaging agents. These data 
revealed significant flexibility within the binding site, which likely regulates partner 
binding. 
 Before the clamp can act on DNA, the sliding clamp loader places the 
clamp onto DNA at primer/template (p/t) junctions. The clamp loader reaction 
couples p/t binding and subsequent ATP hydrolysis to clamp closure. Here we 
show that composition (RNA vs. DNA) of the primer strand affects clamp loader 
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binding, and that the order of ATP hydrolysis around the spiral is likely 
sequential. These studies highlight additional details into the clamp loader 
mechanism, which further elucidate general mechanisms of AAA+ machinery. 
 vii 
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DNA replication and repair: 
Accurate and efficient replication of DNA is an essential process required 
for all cellular life. There is a vast host of players at the replication fork that 
ensure DNA is unwound at the right place and time, and meticulously copied. 
The replication fork moves at remarkably high speeds (~1000 nucleotides per 
second in bacteria) (1), and requires the coordinated efforts of up to 31 different 
polypeptides (as recently discovered in eukaryotic replication) (2). A fascinating 
analogy from Tania Baker and Stephen Bell sets this information to a more useful 
scale: Assuming DNA was 1 m in diameter, the bacterial genome would be 
replicated at roughly 600km/hour using replication machinery that is the size of a 
FedEx truck (3). This analogy also offers a striking example of the accuracy by 
the replication machinery—even given the relatively large size and speed of 
these machines, mistakes would only be made every 170 km (3). However, 
mistakes that are not corrected can compromise genomic integrity, and lead to 
disease. 
 Although DNA polymerase is the major enzyme that carries out DNA 
synthesis, it is joined by a diverse array of molecular machines that regulate and 
coordinate the complex reactions required for DNA replication (Table 1.1). A 
dynamic protein complex known as the replisome carries out this coordination 
(Figure 1.1)(4). A series of regulated replication initiation steps lead to replisome 
assembly, and subsequent replication. This thesis will discuss two proteins at the 
heart of the replisome: the sliding clamp, and the sliding clamp loader.  
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Figure 1.1: Replisomes of bacteria and eukaryotes.  
(A) The bacterial replisome is organized by the clamp loader, which contains a 
tau subunit homotrimer with extensions that bind three C-family DNA 
polymerases and connect to the helicase. The helicase encircles the lagging 
strand. Primase is a single subunit that acts to prime synthesis. DNA loops form 
during Okazaki fragment synthesis as a consequence of the connection between 
the leading and lagging strand polymerases via the clamp loader.  
(B) The eukaryotic replisome is organized by the 11-subunit CMG helicase 
(composed of Cdc45, the Mcm2-7 hexamer which encircles the leading strand 
and the 4-subunit GINS heterotetramer). GINS binds to the leading strand 
polymerase Pol ε. The 4-subunit Pol α-Primase interacts with CMG through the 
Ctf4 homotrimer, which also binds a GINS subunit of CMG. Pol α also extends 
RNA primers to form hybrid RNA-DNA primers. Primers are further extended into 
Okazaki fragments by Pol δ that functions with the PCNA clamp. Direct 
connections of Pol δ and the RFC clamp loader to other replisome components 
are currently unknown, and thus the lagging strand DNA may not form loops. The 
bacterial SSB tetramer and eukaryotic RPA ssDNA-binding proteins protect 
lagging strand ssDNA from nucleases and are not shown for clarity.  
Reprinted with permission from Elsevier, License number 3886000117594.  (5) 
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Replication initiation 
DNA replication initiates at sites in the genome known as origins. Initiator 
proteins bind DNA at origins in order to start the process of replication. All 
initiator proteins are members of the AAA+ ATPase family (ATPase associated 
with diverse cellular activities) (6). Origin recognition and initiator binding follow 
similar principles, with some important differences. Escherichia coli (E. coli) 
contain only a single origin, oriC, which contains several sequence-specific 
regions (7). Multiple copies of the bacterial initiator protein, DnaA, form a helical 
filament and bind at this single origin (8). The DnaA filament uses ATP to unwind 
a single-strand DNA (ssDNA) bubble from which two replications forks form (9). 
Eukaryotic cells contain multiple origins per chromosome; multiple origins are 
necessary in order to replicate larger genomes in a timely manner (10). With the 
exception of the budding yeast Saccharomyces cerevisiae (S. cerevisiae) (11), 
eukaryotic origins do not have as well-defined DNA sequence specificity and 
instead might be defined by DNA nucleosome positioning that allows access to 
the origin (12, 13). The eukaryotic initiator protein is the origin recognition 
complex, ORC (14), which, together with Cdc6, binds to origins (15) The primary 
role of these origin-binding initiator ATPases is to load DNA helicases onto DNA. 
(Table 1.1).  
 Helicase loading and activation is a critical step because it is the limiting 
step for replication; the activated helicase recruits the rest of the replication 
machinery to the replication fork (16). Additionally, once DNA is replicated, 
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subsequent helicase reloading is tightly suppressed to prevent reinitiation in 
order to maintain genome stability (17). Helicases couple ATP hydrolysis to 
strand separation in order to create the leading and lagging strands. In bacteria, 
helicase activation is relatively simple compared to eukaryotes: the AAA+ 
ATPase DnaC helps load the helicase (DnaB) (7) onto the ssDNA region 
unwound by the initiator protein (DnaA) (18). Assembling an active helicase in 
eukaryotic cells is much more complicated than in bacteria. Because eukaryotes 
contain multiple origins per chromosome, replication re-initiation can lead to 
genomic instability (17). Therefore, eukaryotic cells split helicase loading and 
subsequent activation into two defined phases of the cell cycle (13, 16, 19). 
These phases are tightly regulated by additional proteins: during G1 phase, two 
factors, the MCM2-7 complex and Cdt1, bind to the initiator complex ORC:Cdc6. 
This constitutes the pre-replication (pre-RC) complex and its assembly is known 
as origin licensing. The pre-RC complex remains inactive until passage into S-
phase, where the Cdc45 and GINS complex bind to the assembly. This binding 
activates the major replicative helicase complex which is known as CMG (Cdc45, 
the GINS complex, and MCM2-7) (19-21). The active helicase then unwinds the 
double stranded DNA (dsDNA), exposing two ssDNA fragments for bidirectional 
replication. After unwinding, the subsequent replication events are unregulated 
and occur spontaneously. 
The last major initiation step requires primer synthesis at the replication 
fork. No known polymerase initiates DNA synthesis de novo and all cellular 
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polymerases require an initial RNA or DNA primer complementary to the 
template strand. The bacterial and eukaryotic primases, DnaG and Polα 
respectively, synthesize an initial RNA primer as well as primers for the lagging 
strand Okazaki fragments (22). The eukaryotic primase synthesizes a RNA/DNA 
hybrid primer, and acts at Okazaki fragments that form every 100-200bp (23). 
 
The replisome 
All dividing cells contain machinery referred to as a replisome (Figure 1.1) 
to replicate DNA simultaneously on both leading and lagging strands. Replisome 
organization varies between all three forms of life but contains at least six 
different core components: a replicative DNA polymerase, a helicase, a primase, 
a circular sliding clamp, a sliding clamp loader, and single-stranded DNA binding 
proteins (SSB) (Table 1.1) (4, 13). The role of the helicase and primase were 
discussed above. SSBs prevent re-annealing, as well as protect against 
nuclease digestion. DNA polymerases require the sliding clamp for high speed 
DNA synthesis. The clamp is a ring-shaped protein that tethers the polymerase 
to DNA, thus increasing its processivity. However, because the clamp is a closed 
ring, it must be placed onto DNA by the sliding clamp loader (24).  
The bacterial replisome is organized to couple leading and lagging strand 
replication, known as the trombone model. In the trombone model, the lagging 
strand of DNA is looped through the lagging strand polymerase (akin to the 
shape of a trombone), requiring loading and unloading of the sliding clamp, along 
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with primase activity repeatedly along the lagging strand (25, 26). Along with 
helicase DnaB, and primase DnaG, replicative polymerase Pol III is recruited to 
the bacterial replication fork, including accessory proteins β-sliding clamp, and 
the clamp loader τ/γ complex, and SSB (13). The bacterial replisome is 
organized by the clamp loader complex; extensions from the τ subunits contact 
both Pol III at leading and lagging strands, and also contact the DnaB helicase 
(27). The clamp loader complex loads the β-clamp to the primer/template 
junction, formed by the DnaG primase (Figure 1.1a).  
Organization of the eukaryotic replisome differs significantly from bacterial 
replisomes (Figure 1.1b). Three separate polymerases act at the eukaryotic 
replisome: pol ε and pol δ which act on the leading and lagging strands, 
respectively, as well as the primase/polymerase pol α, which initiates primers at 
each Okazaki fragment for the lagging strand (22). Analogous to bacterial SSB, 
the eukaryotic replication protein A (RPA) binds to ssDNA regions on the lagging 
strand after helicase unwinding. The eukaryotic replicative helicase CMG 
encircles the leading strand and enhances leading and lagging strand 
polymerase activity (2). Unlike the bacterial replisome, the eukaryotic clamp 
loader complex, replication-factor C (RFC) does not does directly bind to the 
replicative DNA polymerases or to the replicative helicase (2, 28). Instead, the 
eukaryotic clamp loader serves to open and load PCNA, the eukaryotic sliding 
clamp, onto primed sites of DNA.  
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Replicative polymerases contain proofreading activity to ensure accuracy, 
mistakes occur approximately once every 105 to 106 nucleotides added, 
depending on the fidelity of the polymerase (29). Additionally, replicative 
polymerases often encounter lesions of various sizes on DNA that act like 
roadblocks, causing the polymerase to stall. If the polymerase cannot replicate 
past these lesions, the replication fork can collapse, leading to DNA damage in 
the form of double strand breaks (DSBs). These, and additional types of DNA 
damage require DNA repair pathways, discussed briefly below.  
 
DNA damage and repair 
DNA repair pathways are critical to correct both endogenous and 
exogenous types of DNA damage in order to maintain genome integrity. 
Endogenous damage occurs in the case of replication errors and damage 
caused by reactive oxygen species from metabolic byproducts (30). Exogenous 
damage includes damage caused by lesion-inducing radiation or mutagenic 
chemicals (30). There are a variety of damage response pathways, such as 
direct removal of the DNA damage, damage checkpoint activation, transcriptional 
response, or apoptosis (31). Activating these responses depend on the type and 
severity of DNA damage. In both prokaryotes and eukaryotes, examples of 
pathways used to remove DNA damage are base excision repair (BER), 
mismatch repair (MMR), nucleotide excision repair (NER), and recombinational 
repair. Because DNA replication is tightly linked to the cell cycle, most DNA 
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damage activates checkpoint pathways that prevent premature progression into 
the next phase of the cell cycle (30). Depending on the type of damage, these 
pathways ensure that even a simple remedy of a single damaged base, or 
excision and re-synthesis of long stretch of DNA, can be repaired before cellular 
division. These pathways employ the use of a diverse array of enzymes, 
including, but not limited to nucleases, helicases, polymerases, recombinases, 
ligases, glycosylases, kinases, and phosphatases to maintain genome integrity 
(31).  
Failure of DNA repair often leads to disease. In particular, there are 
several DNA repair disorders, such as ataxia telangiectasia (AT), xeroderma 
pigmentosum (XP), and Cockayne syndrome (CS) that are caused by failure of 
various DNA repair pathways. AT is caused by a mutation in one of the master 
checkpoint kinases, ATM (ataxia telangiectasia mutated) (32). XP is caused by 
mutations in enzymes responsible for NER and patients have a heightened 
sensitivity to UV light (33). Mutations in CSB or CSA, proteins involved in 
transcription-coupled NER repair cause Cockayne syndrome (34). Recently, a 
novel human disorder, ataxia telangiectasia-like disorder-2 (ATLD-2), was 
discovered to share similar clinical features with AT, XP, and CS (Table 1.2). 
ATLD-2 is caused by a single point mutation in the human sliding clamp (35). As 
discussed further below, the sliding clamp facilitates the actions of enzymes that 
function in DNA replication, but it also coordinates multiple cellular pathways 
through its abundant protein interactions.  
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The sliding clamp 
Sliding clamps are essential for processive DNA replication 
Sliding clamps are evolutionarily conserved accessory proteins that tether 
polymerases to DNA. This tethering prevents the polymerase from dissociating 
from DNA, dramatically increasing processivity. For example, bacterial 
polymerase Pol III dissociates from the template after approximately 10 bp in the 
absence of the clamp.  In the presence of the clamp, this distance extends to 
over 80 kb (1, 36). In addition to the polymerase staying bound to DNA, the 
clamp also increases the rate of the replicative polymerase synthesis 40 to 100-
fold in bacterial and phage systems, respectively (37-40). In eukaryotes, the 
presence of clamp and its clamp loader stimulates polymerase activity ~25-30 
fold, thus increasing processive DNA synthesis from ~100bp to ~4kb (41). 
Therefore, without the tethering activity of the clamp, the efficiency of replication 
is severely diminished.  
 
Sliding clamps share a widely conserved structure  
How does the sliding clamp act as a molecular tether? Initial biochemical 
experiments using the E. coli β-clamp elegantly predicted the sliding clamp would 
be ring-shaped and topologically linked to DNA (42). The β-clamp showed tight 
association with circular dsDNA, but easily dissociated after DNA was linearized 
using restriction endonucleases, suggesting the β-clamp “slides” off the end of 
DNA (42). 
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Remarkably, when the first structure of the β-clamp from E. coli was 
published, it was indeed a toroid shaped protein, consisting of a homodimeric 
ring approximately 80Å in diameter (43, 44) (Figure 1.2a). While the structure 
was solved in the absence of DNA, several features suggested how DNA 
associates with the clamp. Despite the fact that clamps are overall negatively 
charged, the β-clamp structure revealed positively charged residues lining the 
central cavity of the clamp, which measures approximately 35Å—wide enough to 
accommodate A- or B- form dsDNA (29). B-form dsDNA modeled into the 
structure had no steric clashes, and molecular simulations predicted DNA 
threaded through the pore between the phosphate-backbone of DNA and 
positively charged side chains lining the pore. Molecular dynamics further 
predicted DNA threaded through the central pore of the clamp (45). This 
hypothesis was later confirmed by a crystal structure of the bacterial β-clamp 
bound to primed DNA (46). This structure revealed that the residues that line the 
clamp’s pore make specific contacts with both ssDNA and dsDNA. However, 
these residues were dispensable for tight DNA-binding, and instead play a 
primary role in directing the clamp loading process (47).  
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Figure 1.2: Clamps from distinct forms of life share a similar architecture 
despite limited sequence conservation. All identical protomers are shown in 
shades of blue. Left: The β-clamp from E.coli is a homodimer (PDB: 2POL) 
Middle and right: The sliding clamps from yeast and bacteriophage are 
homotrimers. (PDBs: 1PLQ and 1B77) (43, 48, 49) 
 
Despite low sequence conservation, the general architecture of sliding 
clamps is highly conserved throughout all domains of life (5, 49, 50). The clamp 
from S. cerevisiae, called proliferating cell nuclear antigen (PCNA) (49), and the 
clamp from bacteriophage RB-69, called gp45 (48) both share the same overall 
architecture as the E. coli β-clamp despite limited sequence similarity. Despite 
only ~15% sequence identity between PCNA and β-clamp, the RMSD after 
alignment on alpha carbons is less than 1Å (49). The major difference between 
these structures is in oligomeric assembly: bacterial clamps are homodimers, 
eukaryotic and viral clamps are homotrimers. Different classes of archaeal 
E. coli
β clamp
S. cerevisiae
PCNA
RB-69 
bacteriophage
gp45
a b c
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clamps use either hetero- and homotrimers (43, 49, 51-53) (Figure 1.2). Each 
protomer contains two subdomains (as in trimeric clamps) or three subdomains 
(as in dimeric clamps). Regardless of the sequence conservation or 
oligomerization all clamps share similar pseudo-hexameric symmetry (48, 49, 54, 
55) reflecting structural and functional conservation. 
A head-to-tail arrangement within the pseudo-hexameric symmetry has 
two important implications for binding partners interacting with the clamp. First, 
the arrangement of the monomers within the ring produces two asymmetrical 
faces of the clamp, termed the N-face and C-face, each possessing distinct roles 
(Figure 1.3). This asymmetry is proposed to orient the polymerase, which binds 
to the C-face, toward the growing end of DNA (44). The N-face serves as the site 
for post-translational modifications for eukaryotic clamps (56, 57). Second, the 
placement of the subdomains within each monomer in a head-to-tail arrangement 
produces a long connection between both subdomains, termed the interdomain-
connecting linker, or IDCL. Dimeric clamps possess two IDCLs while trimeric 
clamps have three. The IDCL protrudes out into solvent on the C-face side of the 
clamp and plays a critical role in PCNA function as the major binding site for 
sliding clamp-interacting proteins.  
  

 17 
The IDCL is a conserved binding site in all sliding clamps 
The co-crystal structure of human PCNA (hPCNA) bound to a peptide 
from the cell-cycle inhibitor, p21CIP1 identified the IDCL as the primary site for 
protein binding (58) (Figure 1.4). The peptide binds each protomer in the ring at 
the IDCL, with an overall 1:1 stoichiometry, and without significant conformational 
changes in hPCNA. The peptide contains a 310 helix, which “plugs” into a 
hydrophobic binding pocket on hPCNA formed primarily by the IDCL and the C-
terminal subdomain (58). The peptide forms additional contacts, including salt-
bridges and hydrogen bonds, along the length of the IDCL. This structure also 
highlighted the importance of the IDCL location; binding to this solvent exposed 
loop does not occlude the pore, which would prevent DNA binding. Importantly, 
binding at the IDCL allows the sliding clamp to be a platform for enzymes that 
then act on DNA. 
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structures also indicate that partner binding generally does not significantly 
change the conformation of the sliding clamp, although a recent study of an 
archaeal protein from Thermococcus kodakarensis discovered a novel inhibitor 
protein, TIP (Thermococcales inhibitor of PCNA) and reveals it distorts PCNA 
and prevents trimer formation (65). 
Because sliding clamps have multiple partner binding sites, they can bind 
more than one partner simultaneously. Therefore, sliding clamps can act as a 
“toolbelt”; multiple ligands can bind simultaneously to then coordinate their 
actions (67). For example, the E. coli β-clamp can simultaneously bind two 
different polymerases, the high-fidelity Pol III, and an error-prone bypass 
polymerase, Pol IV (68). When Pol III stalls on DNA at a lesion, Pol IV can take 
over to replicate past the lesion. Demonstrations of the clamp from the archaeon 
Sulfolobus solfataricus, which is a heterotrimer, coordinates the actions of DNA 
polymerase, the flap endonuclease FEN1 and DNA ligase for Okazaki fragment 
maturation (69, 70). The toolbelt model is less clear in the case of the eukaryotic 
clamp, PCNA, where the clamp might mediate sequential switching of binding 
partners to help coordinate cellular processes (71). Regardless of the exact 
mechanism, the sliding clamp interacts with a variety of proteins at the IDCL, and 
as such, the clamp acts as a platform for these proteins to act on DNA. 
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PCNA interacting partners contain conserved binding motifs 
The majority of the clamp’s binding partners are known as PCNA-
interacting partners, or PIPs. PIPs contain a conserved motif, called the PIP-box, 
defined as a eight-amino acid consensus sequence, QxxΨxxΩΩ, where ψ is a 
hydrophobic residue, L, M, or I, and Ω is either of the aromatic residues, F or Y 
(72). PIPs bind to the C-face side of PCNA at the IDCL. The molecular contacts 
between PCNA and PIPs have been extensively characterized:  to date, there 
are 13 co-crystal structures of WT human PCNA bound to various PIPs (58-62) 
(63-65). The conserved glutamine residue in the PIP-box inserts into a small 
binding pocket on the C-terminal end of PCNA (58). The hydrophobic and 
aromatic residues in the PIP-motif form a 310 helix that binds a larger 
hydrophobic pocket on PCNA. In line with the clamp’s role as a processivity 
factor, most polymerases and many replication proteins contain a PIP-box, but 
PIPs are also found in proteins involved in a diverse array of cellular activities, 
including DNA repair, cell cycle and apoptosis regulation, chromatin remodeling, 
and epigenetic inheritance (Table 1.3) (57). 
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Table 1.3: A subset of PCNA-interacting partners (PIPs) 
 
A second, and lesser-characterized PCNA interaction motif is the AlkB 
homolog 2 PCNA interacting motif, or APIM. The APIM is defined by a five amino 
acid consensus sequence [KR]-[FYW]-[LIVA]-[LIVA]-[KR] (73). APIM interaction 
with PCNA is cell-cycle dependent, as well as partially dependent on post-
translational modifications on PCNA. PIPs and APIMs appear to share a 
common binding site within the hydrophobic pocket created by the IDCL on the 
PCNA C-face, based on site directed mutagenesis within APIMs and competition 
studies (74). To date, there are no co-crystal structures of any APIM bound to 
PCNA, so the exact molecular contacts are yet unknown.  
The textbook view of the clamp’s major function is that of a processivity 
factor, a recent proposal suggests an important role for PCNA as a marker for 
DNA replica,on DNA repair
Pol δ Rfc1 Rad18 MPG
Pol ε Rfc2 Rad5 NTH1
Pol η Rfc4 Msh3 hMYH
Pol κ Fen1 Msh6 APE1
Pol λ Lig1 Mih1 APE2
Pol β Topo IIα EXO1 XRCC1
Rev1 Cdt1 UNG2 XPG
Chroma,n remodeling Cell cycle and apoptosis
CAFI1 p300 CDK2 Cyclin D1
WSTF HDAC1 EGFR Gadd45
Epigene,c inheritance p21 ING1b
DNMT1 p57 p53
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newly replicated DNA (5). PCNA interactions during replication are critical, but 
PCNA interactions facilitate a diverse array of cellular activities besides DNA 
replication (Table 1.3). PCNA’s numerous partners (>100) imply that its role 
exceeds processivity. Indeed, not all polymerases require the clamp; as 
previously mentioned, pol ε is highly active in absence of PCNA (2), and 
replicative DNA polymerases from bacteriophages phi29, T5 and T7 do not 
require a sliding clamp for processive activity (75-78). These additional roles, as 
well as how the clamp interacts with so many additional proteins, will be 
discussed further below.  
 
Additional PCNA roles beyond processivity 
 PCNA interactions facilitate a diverse range of cellular activities beyond 
replication by recruiting enzymes to newly replicated DNA (Table 1.3). As 
previously mentioned, these interactions are mediated by conserved motifs (the 
PIP-box or the APIM-motif) on PCNA partner proteins Additionally, post-
translational PCNA modifications also modulate its interactions with other 
proteins, particularly with proteins involved in DNA damage responses (56). Post-
translational modifications occur on the N-face of PCNA and structural studies 
indicate the modifications do not significantly alter PCNA conformations (79, 80). 
I discuss several examples of PCNA interacting proteins and their diverse 
functions below. 
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PCNA in DNA repair 
PCNA plays an essential role in all types of DNA repair mechanisms 
through its many interactions with DNA repair proteins. PCNA is required for 
mismatch repair (MMR), and associates with mismatch repair proteins within the 
MutSα and MutSβ sensor complexes (81). MMR is strand-specific and the 
process is dependent on having a marker for newly replicated DNA. PCNA may 
assist in this marking newly synthesized DNA because its C-face is oriented 
along the newly synthesized strand.  
Base excision repair (BER) relies on PCNA at nearly every step. PCNA 
interacts with glycosylases, such as UNG2, that remove damaged bases from 
the backbone (82). After glycosylation, APE1 nicks the phosphodiester bond in 
the abasic site, which requires an APE1-PCNA interaction. In short-patch BER, 
Polβ uses PCNA to synthesize the single gap, and the XRCC1-DNA ligase 
complex operates with PCNA to seal the nick. Interestingly, XRCC1 is an 
example of a PIP that does not contain the PIP-box motif. In long-patch repair, 
Pol δ or ε are recruited to PCNA to perform repair synthesis, and both FEN1 and 
DNA ligase I use PCNA to seal the nick, akin to the Okazaki fragment maturation 
process.  
PCNA interacts with several XP proteins implicated in nucleotide excision 
repair (NER). The XPA protein contains an APIM-motif and is thought to be 
directed to sites of damage through its interaction with PCNA (83). The XPG 
protein contains a PIP-box to facilitate nuclease activity required for NER (84). 
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Mutations in XP proteins result in the DNA repair disorder xeroderma 
pigmentosum.  
 Ribonucleotide excision repair (RER) is also dependent on PCNA 
interactions. The RNaseH2 complex is responsible for excising the majority of 
misincorporated rNTPs from DNA (85). The catalytic subunit of the complex, 
RNaseH2B, contains a PIP-box (61) and PCNA localizes RNaseH2B to sites of 
damage, as well as enhances its enzymatic activity (86).  
PCNA also plays important roles in processes preventing double strand 
breaks (DSBs). If the replicative polymerases cannot replicate past a lesion on 
the template strand, monoubiquitinated-PCNA recruits translesion synthesis 
polymerases η, κ or ι to DNA for bypass replication to prevent fork collapse (87, 
88). It is then thought that ISG15 modification (Interferon-Stimulated Gene 15 or 
ISGylation) of PCNA is used to terminate error prone TLS synthesis (89). Finally, 
SUMOylated-PCNA on Lys164 by Ubc9 may play an uncharacterized role in 
preventing recombination by recruiting the anti-recombinogenic Srs2 helicase 
(87) (90, 91). 
 
Cell cycle and apoptosis  
Cell cycle control in eukaryotes is critical for preventing re-replication. 
PCNA interacts with cell cycle regulating proteins, Cdt1 and p21. Cdt1 helps load 
the MCM2-7 complex at sites of origins, and this interaction is critical for 
replication-dependent proteolysis of Cdt1 (92). The PCNA-p21CIP1 interaction 
 25 
inhibits replication by blocking the polymerase-binding site on PCNA; p21CIP1 is 
the tightest-known PIP-box (59, 93). PCNA bound p21CIP1 inhibits binding to 
additional factors, barring any PCNA-mediated processes.  
PCNA both positively and negatively regulates apoptosis. For example, 
PCNA interacts with members of the Gadd45 family via a PIP-box to suppress 
apoptosis (94). In contrast, PCNA interactions with ING1, a tumor suppressor, 
and this interaction increases apoptosis in response to UV light (95).  
 
Epigenetic inheritance, chromatin assembly and remodeling  
 DNA is commonly modified via methylation in order to encode epigenetic 
information. A key contributor to epigenetic methylation markers is the 
methyltransferase DNMT1. DNMT1 contains a PIP-box and localizes to 
replication foci, as well as to sites of DNA repair, via its interactions with PCNA 
(96, 97). Nucleosome assembly pathways are carried out by the histone 
chaperones CAF-1 or the HIR complex. PCNA helps recruit CAF-1 to sites of 
replication so CAF-1 can promote nucleosome assembly (98). 
 
Open questions and scope of thesis 
 Given the large number of PCNA binding partners and functions, PCNA 
must employ mechanisms for spatiotemporal regulation of partner binding. Not all 
PIPs bind to PCNA with the same affinity, so the sequence variation within the 
binding motif may serve as one discriminator for what PCNA can bind and when. 
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Posttranslational modification of PCNA (i.e., ubiquitination or SUMOylation) also 
regulates specificity. Although these methods regulate partner binding, additional 
mechanisms must exist given the large number of binding partners. A clue 
towards PCNA binding regulation comes from a recent study describing a PCNA 
mutant variant.  
 Ataxia telangiectasia-like syndrome 2 (ATLD-2), is caused by the 
Ser228Ile mutation in human PCNA (35). ATLD-2 patients present some clinical 
features that overlap with known DNA repair disorders, such as xeroderma 
pigmentosum, Cockayne syndrome, and ataxia telangiectasia. Patients exhibit a 
combination of symptoms such as microcephaly, hearing loss, abnormal blood 
vessel formation (telangiectasia), heightened sensitivity to sunlight, and 
premature aging (Table 1.2). Initial cell-based studies demonstrated NER is 
disrupted while DNA replication and several other PCNA-dependent functions 
are surprisingly normal (35). For example, PCNAS228I protein levels, localization, 
and DNA replication function are comparable to WT. DNA replication occurs to 
the same extent and same speed as with WT PCNA, as indicated by BrdU 
incorporation and DNA fiber analysis, respectively. However, cell-lines derived 
from affected patients suggested significant defects in NER. Pull-down assays 
and a mass spectrometry study indicated loss of binding partners that act in DNA 
repair pathways. However, the proteins whose PCNA-interactions were disrupted 
in vivo (as measured by mass spec) do not function in NER. Regardless, this 
study revealed a PCNA mutant that affects specific PCNA-regulated pathways 
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while leaving other functions intact (35). 
 This study was surprising given a PCNA mutant caused a very specific 
defect in DNA repair. Given the many PCNA-mediated cellular pathways that 
could be disrupted (DNA replication, nucleosome assembly, chromatin 
remodeling, cell cycle control, epigenetic inheritance), why was DNA repair 
specifically disrupted? Are DNA repair pathways intrinsically physiologically 
fragile, or would disruption of any of the other of PCNA-mediated pathways also 
lead to disease? We sought to use the PCNAS228I mutation as a tool to determine 
how particular pathways are mediated by PCNA function. Specifically, we aimed 
to understand the structural, and biochemical effects of this mutant, which I 
discuss in Chapter II, as well as the cellular effects of this mutant using an in vivo 
model system, which I discuss in Chapter III.    
 
The sliding clamp loader 
 Because the clamp is a closed-ring, it must be actively loaded onto DNA. 
A multi-subunit ATPase, known as the sliding clamp loader, is responsible for 
opening the clamp and placing it at primed sites of DNA (24, 99, 100). The clamp 
loader recognizes primed sites containing a recessed 3’ end, formed by a short 
primer synthesized by primase, and a 5’ template overhang, known as the 
primer/template junction.  The clamp loader couples ATP binding and hydrolysis 
to clamp closure around primer/template junctions, followed by clamp loader 
ejection from both the clamp and DNA (100) (Figure 1.5). A combination of 
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biochemical studies, as well as elegant structures of the clamp loader bound to 
its substrates helped reveal the overall clamp loader binding mechanism. 
Figure 1.5: Clamp loaders and sliding clamps.  
 
(A) Clamp-loading reaction. The clamp loader has low affinity for both clamp and 
primer/template DNA in the absence of ATP. Upon binding ATP, the clamp 
loader can bind the clamp and open it. The binding of primer/template DNA 
activates ATP hydrolysis, leading to ejection of the clamp loader. (B) Three 
classes of clamp loaders. Bacterial clamp loaders are pentamers consisting of 
three proteins: δ (A position), γ (B, C, and D positions), and δ’ (E position). 
Eukaryotic clamp loaders (RFCs) consist of five different proteins, with the A 
subunit containing an A’ domain that bridges the gap between the A and E AAA+ 
modules. The T4 bacteriophage clamp loader consists of two proteins: gp44 (the 
B, C, D, and E subunits) and gp62 (the A subunit). 
Reprinted with permission from AAAS. License number 3873220605050 
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Clamp loader architecture and subunit composition  
 Structural studies of clamp loaders from multiple organisms have 
revealed a conserved architecture of the clamp loader subunits (101-104). All 
clamp loaders are members of the AAA+ family of ATPases, which typically link 
ATP binding and hydrolysis to mechanical motion. (6, 105).  AAA+ proteins are a 
subfamily of the additional strand conserved glutamate (ASCE) family of 
ATPases, contained within the superfamily of P-loop NTPases (106). Clamp 
loaders are unique in that they are pentamers that do not form a closed ring, 
unlike the typical ringed hexamers within the AAA+ family (105). Each subunit 
contains three minimal domains; the N-terminal of domain I contains the P-loop 
responsible for ATP binding (Figure 1.5b) (106). Domain II is made up of a short 
alpha-helical domain termed the “lid” (107). The ATP binding site is at the 
interface of domains I and II, and together, these domains make up the AAA+ 
module (102, 107). Finally, domain III is C-terminal to the AAA+ module and 
oligomerizes to form a disk-like structure referred to as the “collar” (101, 102), 
holding the pentamer together. 
 All clamp loader complexes share a similar subunit organization (Figure 
1.5). The five subunits of the clamp loader assemble into a spiral shape with a 
gap between the first and the fifth subunit. Because the nomenclature for 
different clamp loader subunits has been confusing, a universal naming scheme 
has been employed to describe the identity of five subunits as letters A-E. The A 
subunit is positioned to the right of the gap between the first and the fifth subunit. 
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The remaining B,C,D, and E subunits are arranged counter-clockwise from the 
gap. (102). Non-bacterial clamp loaders also contain an additional subdomain off 
the A subunit called the A’ domain, and this primarily serves as a linker for the 
gap between the A and E subunit, as well as providing an additional contact site 
for the clamp (102-104). Bacterial clamp loaders lack the A’ domain (101), but 
also contain two χ and ψ subunits, which are dispensable for clamp loading 
activity, and tether to SSB within the bacterial replisome to couple clamp loader 
activity to the lagging strand (108).  
 The clamp loader subunit composition and stoichiometry varies across 
life forms. Viral and archaeal clamp loaders consist of two proteins in a 4:1 
stoichiometry, representing the simplest known composition (109). In the T4 
bacteriophage, gp62 encodes for the unique subunit at position A, and gp44 
encodes for the four identical ATPase subunits residing in positions B-E (103, 
110). Bacterial clamp loaders are comprised of three different proteins, γ (or τ), δ 
and δ’, creating an overall 3:1:1 stoichiometry. The non-ATPase subunits δ and 
δ’ occupy positions A and E, respectively (101). In E. coli, the three ATPase 
subunits are encoded by the dnaX gene, which produces a full length, τ subunit, 
or a truncated product, γ, and occupy positions B, C, and D (101, 111, 112). 
Finally, the eukaryotic clamp loader, RFC, consists of RFC1 through RFC5. The  
subunits are arranged 1-4-3-2-5 for positions A-E, respectively (102). All five 
subunits can bind nucleotide (102), but only the ATPase activity of subunits B, C, 
and D are necessary for clamp loading activity (113). Despite these differences in 
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subunit composition, all clamp loader share a similar architecture and overall 
conserved mechanism.  
 
The clamp loader reaction  
 The clamp loader coordinates activity through its three substrates: ATP, 
the sliding clamp, and primer/template DNA (Figure 1.6) Early biochemical 
studies revealed the clamp loader opens the clamp and loads it onto 
primer/template DNA in an ATP-dependent manner, raising significant questions 
about the order of substrate binding, and how hydrolysis is coupled to clamp 
closure (114, 115). Several important structural studies (102-104, 116) helped 
elucidate these questions and build a model for the conserved clamp loader 
reaction. I will discuss the order and implications of binding events in the clamp 
loader reaction below. 
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Figure 1.6. A detailed mechanism for the clamp loading reaction.  
The reaction cycle for the T4 clamp loader is shown as a schematic diagram. (1) 
In the absence of ATP, the clamp loader AAA+ modules cannot organize into a 
spiral shape. (2) Upon ATP binding, the AAA+ modules form a spiral that can 
bind and open the clamp. (3) Primer/template DNA must thread through the gaps 
between the clamp subunits I and III and the clamp loader A and A ́ domains. (4) 
Upon DNA binding in the interior chamber of the clamp loader, ATP hydrolysis is 
activated, most likely through flipping of the switch residue and release of the 
Walker B glutamate. (5) ATP hydrolysis at the B subunit breaks the interface at 
the AAA+ modules of the B and C subunits and allows closure of the clamp 
around primer/template DNA. Further ATP hydrolyses at the C and D subunits 
dissolve the symmetric spiral of AAA+ modules, thus ejecting the clamp loader 
because the recognition of DNA and the clamp is broken. The clamp is now 
loaded onto primer/template DNA, and the clamp loader is free to recycle for 
another round of clamp loading. (103) 
Reprinted with permission from AAAS. License number 3873220605050 
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ATP binding   
  Prior to binding the clamp and loading it onto DNA, the clamp loader must 
first bind ATP (Figure 1.6).  ATP binding drives a conformational change in the 
clamp loader, which brings the subunit interfaces together using an “arginine 
finger” (101, 114, 117, 118). The arginine finger is a residue that reaches into the 
active site of a neighboring subunit to stabilize the negative charge on the γ-
phosphate, and is a conserved residue within the AAA+ family (106). ATP 
binding therefore causes a conformational change that primes clamp loader for 
clamp binding. 
 
Clamp binding 
 After ATP-binding, the clamp loader can bind and open the sliding clamp. 
How the clamp loader opens the sliding clamp differs slightly across life forms, 
due to the differences in stability of the sliding clamp ring across species. The E. 
coli clamp forms a very stable ring that has a dimer dissociation constant in the 
pM range (119, 120). Thus, the clamp loader must somehow force the dimer 
interface open. The structure of the E. coli δ clamp loader subunit bound to a β-
clamp monomer demonstrates δ distorts the curvature of the monomer, likely 
opening the interface between the β-clamp dimer (121). This study suggested the 
clamp loader acts as a “wrench” to force the clamp open. This structure lacks the 
rest of the clamp loader subunits γ and δ’, but δ is capable of binding to the β-
clamp alone in the absence of ATP. In the E. coli system, ATP is then required 
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for DNA binding and clamp closure (115). 
 Bacteriophage T4 clamp loader likely binds to an open clamp. 
Bacteriophage T4 clamp is the least stable clamp in solution (119), and is 
thought to frequently sample an open conformation. Therefore, the T4 clamp 
loader likely traps a transient open conformation (103, 122) instead of actively 
prying it open, as was seen with the E. coli clamp loader. One T4 crystal 
structure that contains two complexes in the asymmetric unit shows the clamp 
open in one clamp loader:clamp complex and closed in the other complex (103). 
In the crystal structure there are extensive contacts between the clamp loader 
subunits and the clamp. The clamp changes conformation from planar ring to a 
right-handed lockwasher (54, 103). This conformational change adopts a spiral 
that matches the helical symmetry of DNA, which has important implications for 
primer/template DNA binding, discussed below.  
 It is not clear whether the eukaryotic RFC clamp loader actively opens 
PCNA (as in the E. coli β-clamp) or traps an open conformation (as in the T4 
gp45 clamp). Compared to the sliding clamps from E. coli and T4 bacteriophage, 
PCNA has intermediate stability (119, 120). The field currently lacks a structure 
of the clamp loader bound to an open clamp in the absence of DNA, but a 
crystallographic study revealed the structure of the eukaryotic clamp loader RFC 
bound to a closed PCNA clamp in the presence of the slowly hydrolyzable 
nucleotide analog ATPγS (102). This structure likely represents an encounter 
complex; nucleotide and the clamp have bound, but the clamp remains closed. 
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The next putative step would be opening of the clamp, followed by 
primer/template binding. 
 
Primer/template binding 
 The structure of RFC bound to closed PCNA provided insight into how 
primer/template DNA might thread through the clamp pore (102). Modeling 
dsDNA into the complex illustrates the interior clamp loader spiral matches the 
major grove of dsDNA. The collar domains physically block the modeled 
recessed 3’ primer strand, whereas the 5’ template strand threads the gap 
created between the A and E subunits. These features lead to what is known as 
the “notched screw cap model” for how dsDNA screws up into the inner clamp 
loader chamber, and how the collar domains provide specificity for recognizing 
the 5’ template ssDNA overhang (123). It is worth noting that the arginine fingers 
in each of the clamp loader subunits were mutated to glutamine to prevent ATP 
hydrolysis. As a result, the pitch between subunits is not uniform, distorting the 
spiral symmetry (102). However, several subsequent studies support this 
hypothesis (103, 116).  
 The crystal structure of the E. coli clamp loader bound to primer/template 
DNA revealed the clamp loader AAA+ modules adopt a highly symmetrical right-
handed spiral tracking the minor groove of DNA, and unexpectedly, the clamp 
loader contacts the template strand alone (116). The clamp loader does not 
contact the primer strand, which explains how the clamp loader accommodates 
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both DNA and RNA primers. A study investigating the effects of mutations in the 
clamp loader was also consistent with the interactions of the template strand and 
residues lining the clamp loader central cavity (124). The AAA+ modules also 
induce conformational changes of the dsDNA from B-form to nearly A-form, close 
to the physiologically relevant A-form of a RNA/DNA hybrid (125). Modeling a 
RNA/DNA primer/template into E. coli clamp loader structure suggested the 
clamp loader can accommodate an RNA primer. Thus, the clamp loader spiral 
can accommodate both DNA and RNA primers.  
 The crystal structure of the T4 clamp loader bound to an open clamp and 
DNA supports several previous studies explaining how primer/template binds 
(103). The gap at the open clamp interface is ~9Å wide, which is not wide 
enough to accommodate dsDNA but wide enough to allow ssDNA to pass, 
suggesting that the clamp likely binds ssDNA first. The structure of E. coli β-
clamp bound to the δ-subunit of the clamp loader complex (121) supports this 
mechanism: the δ-subunit “wrench” relaxes the curvature of a β-monomer such 
that a superposition with the closed E. coli clamp (43) shows a ~15Å gap 
between the dimer interface. This is wide enough for ssDNA passage, but not 
wide enough for dsDNA (121). Similar to the E. coli clamp loader structure bound 
to primer/template DNA (116), the T4 complex structure also revealed 
primer/template DNA adopted an A-form conformation. Importantly, the T4 
structures also suggested how DNA binding is coupled to ATP hydrolysis using 
an allosteric “switch” residue discussed below.  
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ATP hydrolysis and clamp loader ejection 
 DNA binding is directly coupled to ATP hydrolysis, and subsequent clamp 
loader ejection from the closed clamp bound to primer/template DNA (118, 126, 
127). The switch residue (Lys80 in T4 gp44 subunits; Lys100 in E. coli γ 
subunits) is a conserved basic residue that interacts with the catalytic glutamate 
in the Walker B motif preventing it from catalyzing ATP hydrolysis (103, 116, 
124). Upon DNA binding, the phosphate-backbone of the template strand directly 
contacts the switch residue, which releases the catalytic glutamate to assume its 
active conformation for ATP hydrolysis. 
 ATP hydrolysis triggers a rigid-body conformational change in AAA+ 
module of the clamp loader. One of the crystal structures of the T4 clamp loader 
bound to clamp, nucleotide, and primer/template DNA shows one subunit, the B 
subunit, has hydrolyzed ATP (103). In the ADP bound state, the AAA+ module 
from the B-subunit moves ~7Å away from the C-subunit. This conformational 
change allows clamp closure. The B-subunit movement breaks the spiral 
symmetry within the clamp loader subunits, and also breaks clamp interactions, 
explaining why the clamp is closed in the hydrolyzed structure. Continued 
hydrolysis of the other subunits would therefore eject the clamp loader from the 
clamp:primer/template complex. 
 
Open questions and Scope of thesis  
 While the structural and biochemical data provide a detailed view of the 
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clamp loader reaction, there are several open questions. A major question is how 
the clamp loader recognizes and binds primer/template DNA that uses a RNA 
primer. All structures and most biochemical data have used a DNA/DNA 
primer/template, which partially satisfy our understanding of eukaryotic clamp 
loaders, but not prokaryotic or viral clamp loaders. Eukaryotes use the dual 
primase/polymerase, Pol α to synthesize a hybrid primer strand containing both 
RNA and DNA (128, 129). However, bacteria and bacteriophage both use 
primers comprised entirely of RNA (22). Given the sheer abundance of these life 
forms on earth (130, 131), the most common substrate for the clamp loader 
would be a RNA/DNA primer/template. The second major gap in knowledge 
concerns how ATP hydrolysis proceeds around the spiral. The clamp loader 
structure showing one subunit has hydrolyzed ATP raises the question whether 
ATP hydrolysis around the ring is random, or ordered. Other AAA+ and ASCE 
members hydrolyze ATP sequentially, such as E1 helicase, Rho helicase, and 
the phi29 motor (132-134). We wanted to understand the mechanism by which 
the clamp loader would recognize an RNA primer, as well as investigate the 
order of ATP hydrolysis between clamp loader subunits, which I will discuss in 
Chapter IV.  
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A disease-causing variant in PCNA disrupts a 
promiscuous protein binding site 
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Introduction 
 The replication of chromosomal DNA requires a highly conserved protein 
complex, known as the sliding clamp, for replicase function. Sliding clamps are 
found in all cellular life, as well as many viruses (4), and are required for cellular 
proliferation (57, 135). All sliding clamps share a similar multi-lobed ring 
structure, despite low sequence homology and different oligomerization states 
between the sliding clamps of eubacteria and those found in archaebacteria and 
eukaryotes (24, 43, 49, 53, 54, 58). In eukaryotes, the sliding clamp is known as 
Proliferating Cell Nuclear Antigen, or PCNA, and forms a homotrimeric assembly 
(58).  
 The sliding clamp surrounds DNA and acts as a processivity factor for DNA 
polymerases and other enzymes that act on DNA. The increase in processivity is 
striking because isolated bacterial replicative polymerases can only synthesize a 
handful of base pairs (~10 bps) before dissociating from the DNA (136), but in 
the presence of the clamp these polymerases catalyze ~80 kbps before 
dissociation (1). Moreover, sliding clamps are critical for the rapid rate of DNA 
replication, increasing the rate of nucleotide incorporation by up to ~100-fold (37-
39). In addition to its role in facilitating DNA replication, PCNA plays a critical role 
in coordinating various cellular networks to ensure for successful copying and 
repair of DNA (5). When damage is too severe for the basal repair machinery, 
PCNA acts to assemble proteins that slow or halt cell cycle progression until the 
damage is treated. PCNA is necessary not only for the faithful transmission of the 
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genetic material, but also for proper inheritance of epigenetic information in the 
form of nucleosome deposition and DNA methylation (96, 137-140). Finally, 
PCNA functions not just within the confines of the nucleus but also in the cytosol 
of neutrophils, where it plays an important but nebulous role in regulating 
apoptosis (141-143).  
 The sliding clamp accomplishes the difficult task of coordinating multiple 
pathways by binding various proteins that then carry out their function on DNA. 
Scores of proteins are capable of binding PCNA but, because PCNA is a 
homotrimer, it can bind up to three ligands simultaneously (68, 70, 144). Thus 
PCNA can act as a ‘toolbelt’ to assemble multiple enzymes that cooperate to 
complete a given task. For example, heterotrimeric archaeal PCNA 
simultaneously binds the replicative DNA polymerase PolB1, Flap Endonuclease 
I (FEN1), and DNA Ligase I to cooperatively catalyze Okazaki fragment 
maturation (70), although this role is less clear in eukaryotes (71). Because of 
PCNA’s complex role in coordinating various activities and enzymes both in 
series and in parallel, PCNA is a ‘hub’ protein that connects multiple different 
pathways and activities within the network of the cell (145).  
 PCNA primarily uses a single site to bind a majority of its interaction 
partners, which are known as PCNA-interacting proteins or PIPs (57, 58, 145). 
Each subunit contains one binding site, with three identical sites lining one face 
of the ring. Each binding site is comprised of a groove formed by the C-terminal 
domain and the interdomain connecting loop or IDCL, with some partners binding 
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to the N-terminal domain as well (58). Most known PIPs use a simple sequence 
motif known as the PIP-box to bind PCNA. The PIP-box motif has a signature 
sequence QxxØxxϑϑ (where is Ø a hydrophobic residue I, L, or M and ϑ is either 
of the aromatic residues F or Y) and forms a 310 helix upon binding within the 
groove formed by the C-terminal domain and the IDCL (58, 59). A second motif, 
known as the AlkB homolog 2 PCNA interacting motif (or APIM), has been 
identified to bind PCNA (73). However, binding of APIM sequences to PCNA is 
largely uncharacterized. Because a large and diverse array of PIPs must bind 
PCNA in a spatiotemporally regulated manner, the factors that control PIP 
binding are critical for proper cellular physiology. As an elegant example of this 
molecular balancing act, yeast harboring a mutated PCNA with increased PIP-
box affinity exhibit severe DNA replication and repair defects (146). Thus, 
interactions with PCNA have evolved to have precise dynamic exchange 
between interaction partners. However, given the complexity of the vast PCNA 
interaction network, the factors that govern PIP binding have been difficult to 
elucidate. 
 A hypomorphic mutation in the human PCNA (hPCNA) gene was recently 
identified to result in an autosomal recessive disorder with symptoms similar to 
DNA repair diseases such as Xeroderma Pigmentosum, Cockayne Syndrome, 
and Ataxia Telangiectasia (35). In patient-derived cells, DNA replication seems to 
proceed normally but nucleotide excision repair (NER) is disrupted. Thus the 
major cause of the disease was ascribed to a defect in NER (35). The specific 
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effect on NER is remarkable because the mutation, conversion of Ser228 to 
isoleucine (S228I), is at a buried site proximal to the promiscuous PIP-binding 
pocket (Figure 2.1). The mutation is hypothesized to alter the binding site, and 
preliminary Stable Isotope Labeling by Amino Acids in Culture (SILAC) mass 
spectrometry experiments suggested that the mutation alters binding of some 
PIPs (35). However, how the mutation affects hPCNA structure and its effect on 
PIP binding affinity are still unknown. 
 Here we report the crystal structure of hPCNA-S228I and identify a major 
disruption of the IDCL and the PIP binding groove. This disruption results in 
idiosyncratic binding defects in several PIP-box peptides. We further show that 
binding of PIP-box peptides to hPCNA-S228I occurs through distinct binding 
modes, with certain inter-molecular interactions overcoming the disruption of the 
PIP binding groove. Our results illustrate the complexity of interactions between 
PCNA and PIPs and highlight novel cellular pathways that may contribute to 
disease. Finally, our results have implications for understanding the plasticity of  
PIP binding. 
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Materials and Methods 
 
Mutagenesis 
 Site-directed mutagenesis was performed using a protocol similar to 
QuikChange (147) using untagged hPCNA-WT in a pET3c vector (kindly 
provided by J. Kuriyan) and primers with the sequence 5’-
ggtgacactcattatgtctgcagatgtaccccttgttgtagag-3’, and 5’-
ctgcagacataatgagtgtcaccgttgaagagagtggagtggc-3’. Enzymes were purchased 
from New England BioLabs. Oligonucleotides for mutagenesis were purchased 
from IDT. 
 
Expression and purification: 
 All proteins were expressed in E. coli BLR-DE3 cells containing either the 
pET3c-WT- or hPCNA-S228I construct. Cultures were grown in 2x-YT media 
containing 100 µg/mL of ampicillin antibiotic at 37°C. After reaching an OD600 
between 0.6-0.8, cultures were incubated at 4°C for 20 minutes before being 
induced with 1 mM IPTG to and placed at 18°C for overnight expression. Cells 
were pelleted by centrifugation, resuspended in buffer A (25 mM Tris pH 7.5, 
10% vol/vol glycerol, 2 mM DTT) and flash frozen in liquid nitrogen.  
 Cell pellets were thawed and lysed via cell disruptor (Microfluidics Inc.) four 
times to ensure sufficient DNA shearing. Lysate was centrifuged at 14,000 rpm, 
for 40 minutes at 4°C. Cleared lysates were filtered and loaded onto sequential S 
and Q columns (GE Healthcare) pre-equilibrated in buffer A. After loading 
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cleared lysates, the S column was removed and Q column was washed with 2 
column volumes of buffer A. PCNA was eluted using a gradient of buffer B 
(25mM Tris pH 7.5, 10% vol/vol glycerol, 2mM DTT, 1M NaCl). PCNA-containing 
fractions eluted between 29%-33% buffer B were pooled and concentrated to 
load onto a Sephacryl-200 gel filtration column (GE Healthcare) pre-equilibrated 
in GF buffer (20mM Tris pH 7.5, 5% vol/vol glycerol, 2mM DTT). hPCNA-
containing fractions were pooled, concentrated to >30mg/mL, flash frozen in 
liquid nitrogen and stored at -80°C.  
 
Crystallization, structure determination and refinement 
 All proteins were crystallized using the hanging drop vapor diffusion 
method. Apo hPCNA-S228I drops were set with final protein concentration 
between 5-20mg/mL and crystals formed in 100mM sodium acetate pH 4.5, 2.0 
M ammonium sulfate. Cryogenic buffer contained elevated amounts of 
ammonium sulfate precipitant supplemented with 25% (v/v) glycerol. Diffraction 
data was collected at Advanced Photon Source beamline 23-ID-B at a 
wavelength of 1.033 Å. For co-crystallization of hPCNA-S288I to p21CIP peptide 
was pre-incubated at 1.5 molar excess of protein (final drop concentration 
between 5-20 mg/mL). Co-crystals formed in 100mM HEPES pH 7.5, 25% PEG 
3350, which also served as the cryogenic buffer supplemented with excess 
p21CIP peptide. Diffraction data was collected at SIBYLS 12.3.1 beam line at the 
Advanced Light Source with a wavelength of 1.000 Å. For co-crystallization of 
 47 
hPCNA-S228I to FEN1pep, peptide was pre-incubated at 1.25 molar excess of 
protein (final drop concentration between 5-20mg/mL). Co-crystals formed in 
2.35 M ammonium sulfate, 100 mM sodium acetate pH 4.6, 40% (v/v) (±)-1,3-
Butanediol. Cryogenic buffer contained elevated levels of ammonium sulfate 
precipitant supplemented with FEN1pep and 20% (v/v) glycerol. Diffraction data 
were collected at Advanced Photon Source beamline 23-ID-B at a wavelength of 
1.033 Å. All datasets were processed using HKL-3000 (148). Structures were 
solved by molecular replacement (MR) using wild-type hPCNA as a search 
model (serine 228 was removed for MR) using Phaser (149). Model building and 
refinement were performed with Coot (150) and PHENIX (151). Analysis in 
phenix xtriage revealed twinning for co-crystals of hPCNA-S228I-p21 and 
hPCNA-S228I-FEN1pep, as has been commonly seen for other hPCNA crystals 
(58, 59). Data for both the p21CIP peptide and FEN1pep could be processed in 
point group P6, but all molecular replacement solutions resulted in unstable 
refinement with high Rwork and Rfree. Therefore, symmetry was reduced to P3, 
and solutions yielded stable refinement with acceptable R values. The twin laws 
[-h,-k,l] and [h,-h-k,-l] were applied throughout refinement for the p21CIP and 
FEN1pep structures, respectively.  
 
Isothermal Titration Calorimetry 
 Thermodynamics of peptide binding to WT and mutant hPCNA were 
determined by isothermal titration calorimetry using a Micro-Cal ITC200 system 
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(Malvern). Peptides  (FEN1pep=STQGRLDDFFKVTGSL-OH; RNaseH2B= 
DKSGMKSIDTFFGVKNKKKIGKV-OH) were purchased from 21st Century 
Biochemicals and synthesized to >95% purity. The p21CIP peptide 
(CGRKRRQTSMTDFYHSKRRLIFS) was a gift from David King, UC 
Berkeley/HHMI. Peptides were solubilized in water and diluted in reducing PBS 
(137 mM NaCl, 2.7 mM KCl, 1 mM TCEP, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 
7.5). hPCNA was buffer exchanged into reducing PBS using PD-10 desalting 
columns (GE Healthcare). In a typical experiment, the peptide ligand (400 µM for 
p21CIP; 750 µM for FEN1pep and RNaseH2B in the syringe) was titrated over 19 
injections of 2 µL into 20-25 µM of hPCNA, thermostated to 30°C in the sample 
cell. The quantity of heat released by peptide binding to hPCNA was measured 
by integrating the area under the curve of each injection peak. The heat of 
dilution of peptide injected into buffer was subtracted from the raw data before 
analysis. Data were analyzed and fit to a one-site binding model using ORIGIN 
software (MicroCal). Errors reported are weighted averages from multiple 
independent experiments (n=4 for hPCNA-S228I with p21CIP; all others n=3). 
  
Structural and Sequence analysis 
 Superposition performed with SuperPose (152) or PyMOL. Buried surface 
area was calculated with 'Protein interfaces, surfaces and assemblies' (PISA) 
service at the European Bioinformatics Institute 
(http://www.ebi.ac.uk/pdbe/prot int/pistart.html(153). Hydrogen bonds calculated 
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using the VADAR server (154). 
 
Results 
Structure of hPCNA-S228I 
 To elucidate how the S228I variant alters hPCNA conformation, we 
crystallized the mutant protein and determined its structure to 2.7 Å resolution 
(Table 2.1). The overall structure of hPCNA-S228I is largely similar to that of 
wild-type (64) (Figure 2.2a), with an global RMSD of 0.7 Å for simultaneous 
superposition of all three chains (152). Moreover, the electrostatic surface within 
the pore of hPCNA-S228I is nearly identical to that of wild-type (Figure 2.3), 
suggesting that the interaction of the sliding clamp with DNA (45-47, 155) is 
unaffected by the S228I mutation.  
 Although the global structure of hPCNA-S228I is similar to wild-type, there 
are substantial changes near and extending away from the mutation site, 
including significant changes in the IDCL. Notably, a residue that contacts the 
mutation site, Tyr133, rotates outwards by nearly 90° to prevent clashing with the 
Ile228 sidechain gamma methyl group (Figure 2.2b). Tyr133 is a highly 
conserved residue (Figure 2.2c) within the IDCL that lines the PIP-binding 
pocket in wild-type hPCNA (Figure 2.1). This rotation of Tyr133 is 
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Figure 2.2: S228I mutation perturbs the IDCL conformation. 
A) Overlay of the structure of hPCNA-S228I with the hPCNA-WT (PDB code 
1VYM (64)). The overall Cα RMSD is 0.7 Å. Images on bottom-left and on 
bottom-right show zoomed-in views of the WT- and hPCNA-S228I comparison, 
from the top and side of the ring, respectively. Any residue that differs in Cα 
position by >2 Å is displayed with red arrows. Most of the arrows are in the IDCL 
and/or PIP binding site. Ile228 is shown as spheres. 
B) The S228I mutation induces a large rotation in Tyr133. hPCNA-S228I (blue) is 
superposed onto the hPCNA-WT structure(64) (gray). The larger steric bulk of 
the isoleucine sidechain forces Tyr133 into an alternate conformation.  
C) Sequence alignment of hPCNA. Top: Residues within the IDCL are highly 
conserved, including tyrosine at position 133 (purple triangle). Bottom: Serine is 
conserved at position 228 (purple triangle), with the exception of S. cerevisiae. 
D) & E) Relative B-factors suggest that the hPCNA-S228I IDCL is less dynamic 
than WT. hPCNA-WT is shown in panel (D) and hPCNA-S228I in panel (E). The 
thickness and color of the chain are scaled by the normalized B factor (low to 
high B factor = thin to thick, blue to red). The highest flexibility is seen in the IDCL 
and in a few surface loops. 
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unprecedented in hPCNA; in the 15 different crystallographic structures of 
hPCNA (with ligands and without) (58-62, 64, 157-159), none show a significant 
change in the conformation of Tyr133 (Figure 2.4a). The ‘flipped out’ orientation 
of Tyr133 is the predominant conformation but is likely not the sole conformation 
populated, because Fo-Fc maps reveal significant positive density adjacent to the 
modeled conformation of Tyr133. This flat-shaped density is found in all three 
subunits and can be strengthened by averaging the maps over non-
crystallographically related PCNA protomers (Figure 2.5a). Superposition of the 
hPCNA-WT structure places the canonical conformation of Tyr133 into this 
density. However, our attempts to model this alternative conformation, even at 
low occupancy, lead to an increase in Rfree and decreased map quality. Thus our 
results suggest that Tyr133 accesses the canonical conformation but with an 
occupancy too low to accurately model.  
 The rotation of Tyr133 significantly perturbs the entire IDCL, with substantial 
conformational changes observed in IDCL residues far from the site of the 
mutation. In all three copies of hPCNA in the asymmetric unit, we observe a 
similar conformation of the IDCL (Figure 2.4b). This result suggests that the 
altered IDCL conformation is not due to crystal packing forces because each 
hPCNA protomer experiences a different crystalline environment. The 
conformational changes in the IDCL are mainly composed of twisting motions of  
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the backbone, such that each residue’s sidechain is oriented in a different 
direction than in the canonical IDCL configuration. The twisting motion is 
prevalent even out to Asp120, which is thirteen residues and ~39 Å away from 
Tyr133. Thus, the local change in the orientation of Tyr133 triggers long-range 
reorganization of the IDCL.  
 Despite the substantial disruption of the canonical IDCL conformation, the 
B-factors for the IDCL of hPCNA-S228I are relatively low as compared to those 
of the wild-type IDCL. To quantify these changes, we normalize the B-factors of 
the IDCL residues to the average of the entire hPCNA protein. We observe that 
the normalized B-factors for the IDCL of wild-type hPCNA are ~40% higher than 
those from hPCNA-S228I (Figure 2.2d&e). This result suggests that the S228I 
mutation results in a perturbation of the IDCL dynamics, in addition to the more 
obvious changes in conformation. 
 
S228I mutation disrupts PIP binding 
 Because the IDCL constitutes the majority of the PIP-box interaction 
surface, the conformation of PIP-box binding pocket is substantially disrupted in 
S228I. The molecular surface near the PIP-box binding groove is significantly 
different than in hPCNA-WT (Figure 2.6a&b). The volume and depth of the 
binding groove appears much smaller and shallower than the hPCNA-WT. To 
quantify this change, we measured the size and shape of the PIP-box binding 
cavity using the program CAVER (160). This analysis revealed  
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Figure 2.5: Stereo diagram of NCS averaged difference maps.  
Green and red mesh represent positive and negative density, respectively.  
A) NCS-averaged difference (Fo-Fc) map of apo hPCNA-S228I contoured at 
3.5σ. The structure of WT-hPCNA (translucent gray) is superposed onto that of 
hPCNA-S228I. Note that the ‘flipped-in’ conformation of Tyr133 fits the positive 
density adjacent to the ‘flipped-out’ Tyr133 conformation that is modeled (blue). 
B) NCS-averaged difference (Fo-Fc) map of hPCNA-S228I bound to the p21CIP 
PIP-box peptide contoured at 2.25σ. The structure of apo hPCNA-S228I 
(translucent purple) is superposed onto that of hPCNA-S228I:p21CIP (blue). Note 
that no significant positive density corresponds to the ‘flipped-out’ conformation. 
C) NCS-averaged difference (Fo-Fc) map of hPCNA-S228I bound to FEN1pep 
contoured at 2.25σ. The structure of hPCNA-WT bound to FEN1pep (translucent 
gray) is superposed onto that of hPCNA-S228I:FEN1pep (blue). Note that no 
significant positive density corresponds to the ‘flipped-in’ conformation. 
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Figure 2.5: Stereo diagram of NCS averaged difference maps. 
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that the cavity in hPCNA-S228I is only ~33% of the volume observed in wild-type 
and the shape of the binding pocket is greatly altered (Figure 2.6c&d). 
Moreover, superposition of the PIP-box motif from RNaseH2B (61) into the 
hPCNA-S228I binding pocket reveals that the observed conformation is 
incompetent for PIP-box binding (Figure 2.6e). In fact, superposition of all known 
PIP-box motifs (58, 59, 61, 62, 64, 157) results in steric clashes. Given these 
results, we hypothesize that the S228I mutation disrupts PIP binding.  
 To test our hypothesis, we focused on the PCNA binding regions of three 
different PIPs: (1) p21CIP, a cell cycle regulation protein(161), (2) the DNA repair 
protein RNaseH2B, a subunit of the RNaseH2 complex that degrades R-loops 
and single rNMPs incorporated into DNA during replication(162), and (3) Flap 
Endonuclease I (FEN1), which functions in both DNA replication (Okazaki 
fragment maturation) and DNA repair (base excision repair) (163). We 
investigated the binding of FEN1 and RNaseH2B because the previous SILAC 
experiments(35) suggested that these two PIPs had differential binding in 
response to the S228I mutation: FEN1 showed decreased binding to the disease 
variant, and RNaseH2B showed increased binding. Although the SILAC 
experiments suggest relative changes in binding, this method does not provide a 
quantitative measurement of binding affinity and is prone to artifacts(164). p21CIP 
was chosen for study because it is the tightest binding PIP-box sequence 
known(165) and  
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Figure 2.6: Disruption of the binding site in hPCNA-S228I.  
A & B) The binding site surface of hPCNA-S228I is altered. (A) The surface of 
apo hPCNA-WT is shown from the top of the ring with the binding site for the 
second aromatic residue of the PIP-box motif outlined in green. (B) The surface 
of hPCNA-S228I is shown with the same binding site outlined in green. 
C) & D) Constricted binding site volume in hPCNA-S228I. The volume of the 
binding pocket is shown as space-filling volume as calculated by Caver(160). 
The volume of the hPCNA-WT (panel C; gray) binding pocket is substantially 
larger than hPCNA-S228I (panel D; blue). View is shown from the side of the 
ring.  
E) Binding pocket is incompatible with PIP-box binding. The structure of hPCNA 
bound to the PIP-box motif of RNase H2B is superposed onto the apo hPCNA-
S228I structure (only RNase H2B peptide is shown). The constricted binding site 
would clash with the PIP-box, most notably at Phe301 of RNase H2B, which is 
the second aromatic residue of the PIP-box motif. 
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has been useful for crystallographic (58) and binding studies (59, 93, 166). 
 We measured the binding affinity of these three peptides by isothermal 
titration calorimetry (ITC). We found that all three peptides lose affinity for S228I 
relative to hPCNA-WT (Table 2.2), contrary to what was predicted by SILAC(35). 
However, the magnitude of the effect is dependent on the particular PIP-box 
sequence. hPCNA-S228I exhibits only a subtle (~0.2 kcal/mol) loss in binding 
energy for the tight-binding p21CIP PIP-box peptide (Kd,wt = 560 ± 140 nM, Kd,S228I 
= 810 ±  20 nM) (Figure 2.7a). In contrast hPCNA-S228I has a much larger loss 
in affinity for the PIP-box peptides derived from RNaseH2B or FEN1. The FEN1 
PIP-box peptide binds hPCNA-WT with a Kd of 9.7 ± 0.4 µM but has no 
measurable affinity by ITC for hPCNA-S228I (Figure 2.7b). Some heat evolves 
upon titration of the FEN1 PIP-box with hPCNA-S228I, illustrating that the 
enthalpy of binding of FEN1 peptide is greatly reduced for hPCNA-S228I. 
However, the small heat of binding is not sufficient to fit the data to obtain reliable 
estimates of the Kd or thermodynamics parameters of binding. Likewise, the PIP-
box peptide from RNaseH2B binds hPCNA-WT with a Kd of 35 ± 1 µM, but there 
is no measurable binding with hPCNA-S228I (Figure 2.7c). In this case, there is 
negligible heat evolved upon titration of the RNaseH2B peptide with hPCNA-
S228I above that of the heat of peptide dilution, suggesting significant 
impairment of binding. Thus, the S228I mutation has idiosyncratic effects on the 
binding of different PIP-box motifs.  
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Figure 2.7. Affects of the S228I mutation on binding energetics of select 
PIP-box motifs. ITC data for WT- and hPCNA-S228I with various PIP-box 
peptides. See Table 2.2 for results.  
A) ITC measurements for WT- and hPCNA-S228I with p21CIP peptide. 
B) ITC measurements for WT- and hPCNA-S228I with FEN1 peptide. 
C) ITC measurements for WT- and hPCNA-S228I with RNaseH2B peptide. The 
third column shows titration of the RNaseH2B peptide into buffer, which gives the 
heat of peptide dilution. Note that the heat evolved upon titration with hPCNA-
S228I is of the same scale as the heat of dilution, suggesting no significant 
interaction between peptide and protein. 
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contain three separate chains per asymmetric unit which are organized into an 
unusual arrangement in which each of the three hPCNA subunits in the 
asymmetric unit forms a separate three-fold symmetric ring within the context of 
the overall crystal (Figure 2.8). Thus there are three independent rings of 
hPCNA arranged in the crystal. Each ring is similar to the others with obvious 
density for the p21CIP peptide bound (Figure 2.9a). The IDCL conformation in 
hPCNA-S228I is substantially altered upon p21CIP peptide binding (Figure 2.9b). 
Even though isolated p21CIP is an intrinsically disordered protein(167), the core 
PIP-box motif forms a 310-helix upon binding PCNA, while the region from Ser153 
to Phe159 of p21CIP forms an anti-parallel sheet with residues 120 through 126 of 
the IDCL. This conformation is essentially the same conformation as observed 
for hPCNA-WT (58) (Figure 2.9c). Importantly, Tyr133 of hPCNA reverts to the 
canonical conformation seen in all structures of hPCNA-WT, with the exception 
that the entire residue is shifted upwards by ~1Å away form Ile228 (Figure 2.9d). 
Moreover, p21CIP buries the same amount of area for both hPCNA-WT and 
hPCNA-S228I (2150 ± 10 Å2 and 2147 ± 80 Å2, respectively). The IDCL also 
becomes more ordered upon p21CIP binding with the IDCL B-factor higher by only 
~10% than the overall protein B-factor for both wild-type hPCNA and the S228I 
mutant (Figure 2.10a&b). 
 To investigate why p21CIP PIP-box binding affinity is largely unaffected by 
the S228I mutation, we used the crystal structure to examine key interactions.  A 
possible explanation for the small effect on p21CIP PIP-box affinity is that a  
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Figure 2.9: Structure of hPCNA-S228I bound to the p21CIP1 PIP-box motif.  
A) p21CIP1 peptide is bound to hPCNA-S228I. Omit density (Fo-Fc) is contoured at 
2.5 σ , which shows clear density for the peptide. p21CIP PIP-box peptide is 
shown in green. 
B) The hPCNA-S228I IDCL changes conformation upon p21CIP1 PIP-box binding. 
Superposition of apo and p21CIP1 PIP-box bound hPCNA-S228I (pink and blue, 
respectively) shows that the IDCL changes conformation substantially from the 
unbound state. 
C) The hPCNA-S228I reverts to the canonical IDCL conformation upon p21CIP1 
PIP-box binding. Superposition of p21CIP1 PIP-box bound WT- and hPCNA-S228I 
(gray and blue, respectively) indicates that all residues in the IDCL are in nearly 
the same conformation as in the canonical conformation. Hydrophobic interaction 
between Pro129 and Tyr151 shown with purple disks.  
D) S228I mutation forces Tyr133 closer to the p21CIP1 peptide. The larger steric 
bulk of isoleucine 228 forces the Tyr133 sidechain upward toward the p21CIP1 
peptide. Tyr133 packs tighter against Tyr151 of p21CIP1 than is observed in the 
hPCNA-WT structure (4.3 vs 4.6 Å).  
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Figure 2.9: Structure of hPCNA-S228I bound to the p21CIP1 PIP-box motif.  
  
a
c
b
d
p21CIP1 pep)de
hPCNA.S228I
hPCNA.S228I (apo)
p21CIP1 (WT)
hPCNA.WT, p21CIP1 bound
Ser/Ile228
Tyr133
Tyr151
Ser134 Tyr133
Glu132
Gln131
Glu130
Pro129
Gln125
Tyr151
His152
Ser153
Met147
Phe150
Gln144
Asp149
Ser134
Tyr133
Glu132
Gln131
Glu130
Pro129
Gln125

 70 
FEN1 PIP-box binding induces a novel conformation of the IDCL 
 To determine how the S228I mutation affects binding of other PIP-box motif 
sequences, we also crystallized a complex of the FEN1 PIP-box peptide 
(hereafter referred to as FEN1pep) with hPCNA-S228I. Although the binding 
thermodynamics of FEN1pep to hPCNA-S228I are greatly altered relative to 
hPCNA-WT (Figure 2.7b), at high peptide concentrations we were able to 
produce co-crystals whose growth was dependent on the presence of the 
peptide. The structure was solved to 2.1 Å resolution by molecular replacement 
and refined using twin law h,-h-k,-l (Table 2.1). In both copies of hPCNA in the 
asymmetric unit, FEN1pep is bound at high occupancy with clear density for 
nearly all residues in the peptide (Figure 2.11a). 
 The hPCNA-S228I:FEN1pep structure reveals a third and novel 
conformation of the IDCL. While the overall PCNA fold of the S228I variant is 
similar to the hPCNA-WT: FEN1pep structure (59) (Cα RMSD = 0.8 Å), the IDCL 
adopts a different conformation than has been observed in all other hPCNA 
structures, WT or mutant. A structural comparison of hPCNA-S228I:FEN1pep 
with either apo hPCNA-S228I or hPCNA-WT:FEN1pep reveals that the N-
terminal portion of the IDCL (distal to the mutation; residues 120-125) adopts the 
canonical conformation as seen in structures of PCNA-WT (Figure 2.11b&c). 
However, the C-terminal portion (proximal to the mutation; residues 126-134) 
adopts a novel conformation that is distinct from the canonical conformation 
(Figure 2.11b). This conformation is somewhat similar to that seen in apo 
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hPCNA-S228I in that Tyr133 ‘flips-out’ into the non-canonical conformation; 
however, the backbone conformation is altered from that of the apo S228I form 
(Figure 2.11c). Thus, the IDCL architecture of hPCNA-S228I:FEN1pep 
represents a novel conformation.  
 Despite the large changes in the IDCL conformation in hPCNA-S228I, the 
interaction surface for FEN1pep is very similar to that in hPCNA-WT. The binding 
interface is rearranged in hPCNA-S228I such that the pocket for the central 
residue of the PIP-box motif (Leu340 of FEN1pep) is essentially identical to that 
seen in wild-type. The binding pocket for the second aromatic residue (Phe344 of 
FEN1pep) has a different conformation that closes more tightly to seal off the 
binding pocket (Figure 2.11d&e). However, this constriction does not alter the 
overall FEN1pep interaction surface area; FEN1pep buries a roughly equivalent 
surface area for both WT- and hPCNA-S228I (1380 Å2 and 1390 Å2, 
respectively). Moreover, the hydrogen bonding pattern with FEN1pep is similar in 
both S228I- and hPCNA-WT (Table 2.3). Thus, the interactions observed 
crystallographically are nearly identical between WT- and hPCNA-S228I with the 
exception that hPCNA-WT has a binding site that is largely prearranged whereas 
the hPCNA-S228I binding site must reorganize to accommodate FEN1pep. 
Despite the prearrangement of hPCNA-WT, the wild-type IDCL is significantly 
more dynamic than in hPCNA-S228I; the average IDCL B-factor is ~2.3-fold 
higher than the average for the entire hPCNA-WT protein, while the S228I IDCL 
is only ~1.3-fold higher than the protein average (Figure 2.12). 
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Figure 2.11: Structure of hPCNA-S228I bound to the FEN1 PIP-box motif. 
A) FEN1 peptide is bound to hPCNA-S228I. Omit density (Fo-Fc) contoured at 2.5 
σ shows clear density for the peptide. FEN1pep shown in tan color. 
B) Comparison of WT- and hPCNA-S228I IDCL conformations upon FEN1pep 
binding. Superposition of FEN1pep bound WT- and hPCNA-S228I (gray and 
blue, respectively). The N-terminal half of the hPCNA-S228I IDCL reverts to the 
canonical IDCL conformation upon FEN1pep binding. However, the C-terminal 
region of the IDCL (in and around Tyr133) is distinct from the canonical 
conformation. Any residue that differs in Cα position by >2 Å is displayed with red 
arrows. 
C) The entire hPCNA-S228I IDCL shifts upon FEN1pep binding. Superposition of 
apo and FEN1pep-bound hPCNA-S228I (pink and blue, respectively). Even 
though Tyr133 is in the ‘flipped out’ orientation, the conformation of the S228I 
IDCL is distinct from the apo state. Any residue that differs in Cα position by >2 Å 
is displayed with red arrows. 
D) & E) Different shapes of the PIP binding groove for WT- and hPCNA-S228I 
upon FEN1pep binding. The molecular surface of WT- (panel D; gray) and 
hPCNA-S228I (panel E; blue) are displayed from above with FEN1pep shown as 
a translucent trace to allow visualization of the underlying pocket. The dotted oval 
indicates the major structural differences in the binding pockets of S228I and wild 
type. The hPCNA-S228I pocket is slightly more constricted but has no significant 
change in interaction surface area with FEN1pep.   
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(Figures 2.9&2.11). Therefore, the structural and sequence factors that control 
PIP binding in hPCNA-S228I are more complex than simple reversion of the 
IDCL conformation.  
 Our structural and thermodynamic investigation of p21, FEN1 and 
RNaseH2B binding highlights several factors that determine how PIPs are 
selectively perturbed by the S228I mutation. First, we observe a correlation 
between the overall binding affinity of the binding partner and the extent of its 
disruption; the high affinity PIP-box from p21CIP is the least disrupted while the 
low affinity interaction with the RNaseH2B PIP-box is the most disrupted. While 
high affinity binding by itself cannot prevent PIPs from being affected by the 
S228I mutation, work described here and elsewhere shows that high affinity PIP 
binding is associated with a larger interaction surface area between the PIP and 
PCNA (59, 61). A larger surface area provides more opportunity for new 
interactions between PCNA and the PIP to compensate for the energetic cost of 
IDCL reorganization. With this concept in mind, we will more carefully examine 
the binding features of p21CIP and FEN1pep below. 
 Why is p21CIP binding largely unaffected by the S228I mutation? We ascribe 
the minor reduction in p21CIP binding affinity to two effects: (1) the ability of the 
IDCL to revert to the canonical conformation, and (2) additional packing 
interactions between the IDCL and the p21CIP PIP-box peptide.  Although 
reversion of the IDCL to the canonical conformation allows PCNA to maintain 
many interactions with p21CIP peptide (Figure 2.14), we observe slightly more 
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hydrogen bonds between p21CIP and hPCNA-WT than with hPCNA-S228I (Table 
2.4). The small decrease in overall hydrogen bonding of S228I with p21CIP is 
predicted to reduce the enthalpy of binding, which must be compensated by the 
entropy of binding to keep the overall affinity near iso-energetic.  The altered 
dynamics of S228I IDCL potentially contributes to this compensation. While our 
data are consistent with an entropy-enthalpy compensation mechanism, the 
measurement errors for the thermodynamic parameters are too large for a 
definitive conclusion. The second factor limiting the deleterious effects of the 
S228I mutation on p21CIP binding is a new interaction that is absent or weak in 
hPCNA-WT; Tyr133 shifts to accommodate the clash with Ile228 and in doing so 
packs more tightly against Tyr151 of p21CIP. This augmented interaction may be 
especially important because Tyr151 of p21CIP is regarded as a ‘molecular tether’, 
critical for p21CIP affinity (165). We hypothesize that strengthening this interaction 
is a source of binding energy compensation for p21CIP with hPCNA-S228I. Tyr151 
of p21CIP lies at the second aromatic position within the conserved PIP-box 
consensus sequence QxxØxxϑϑ, and is the only tyrosine at this position in the 
PIP-box in all known human PIP-box sequences (171). Therefore this proposed 
mechanism for binding energy compensation is likely to be unique to p21CIP.  
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 The forces driving interaction between FEN1pep and hPCNA-S228I are 
less clear. Whereas FEN1pep binding to hPCNA-WT evolves adequate heat for 
curve fitting in ITC, the enthalpy of binding is severely reduced for the S228I 
variant such that we cannot confidently determine the affinity. However, our 
structural data hints as to how the mutated binding site accommodates 
FEN1pep. The hPCNA-S228I:FEN1pep complex structure shows that the IDCL 
adopts a third conformation that is essentially a hybrid of the canonical and apo-
S228I conformations, where Tyr133 adopts the “flipped out” conformation and 
the N-terminal region forming the canonical conformation. Although the entire 
IDCL shifts back to the canonical conformation upon p21CIP binding to hPCNA-
S228I, only the regions with significant contact to FEN1pep adopt the canonical 
conformation; the rest forms a novel conformation. Therefore, we propose that 
the total surface area of the IDCL interaction with PIP-box peptide determines 
which conformation is adopted. Regardless of the large differences in IDCL 
conformation between WT- and hPCNA-S228I, the PIP binding sites appear to 
make comparable interactions with FEN1pep as measured by either buried 
surface area or number of hydrogen bonds formed (Figure 2.15 and Table 2.3).  
 Our results indicate IDCL flexibility and dynamics control the binding of PIPs 
to hPCNA-S228I. We observe three different IDCL conformations indicating that 
the IDCL is dynamic and pliable in hPCNA-S228I. The apo form predominantly 
adopts a novel conformation with Tyr133 flipped away from the PIP binding 
pocket, while also populating the canonical Tyr133 conformation to a lesser 
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extent (Figure 2.5a). In contrast, p21CIP binding induces the IDCL to assume the 
canonical conformation at or near 100% occupancy (Figure 2.5b). FEN1pep 
binding induces a third conformation with Tyr133 fully in the non-canonical 
conformation (Figure 2.5c). Thus, the IDCL is energetically balanced between 
the canonical and non-canonical conformations of Tyr133; peptide binding can tip 
this balance in favor of either one or the other state. The inherent conformational 
flexibility of the IDCL allows it to wrap around different PIP-box motifs in different 
conformations in order to recover interaction surface area with the peptide. Thus, 
hPCNA-WT uses a classical ‘lock-and-key’ mechanism (172) in which the IDCL 
is predominantly prearranged to accept peptides with minimal conformational 
change (58, 59, 64), while hPCNA-S228I undergoes substantial backbone 
rearrangements to form the PIP-box binding pocket in an ‘induced fit’ mechanism 
(173). Additionally, our ITC results point to a larger entropic component to PIP 
binding in hPCNA-S228I, which again argues for a role of IDCL flexibility in PIP 
binding. Although the reduced enthalpy of binding for both FEN1pep and 
RNasH2pep makes binding affinity measurements unreliable or impossible, we 
propose that an entropy compensation mechanism for FEN1pep allows for 
productive binding at the high concentrations used in co-crystallization 
experiments. This potential entropic contribution to binding again points to 
flexibility and dynamics as playing an increased role in binding to hPCNA-S228I. 
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 Could the conformations of the variant reflect the flexibility of the IDCL in 
hPCNA-WT? Several lines of evidence indicate that the wild-type IDCL is quite 
flexible and undergoes regular dynamic transitions between different 
conformations. Crystallographic studies suggest that the wild-type IDCL is 
dynamic because B-factors in the IDCL are nearly two-fold higher than the 
average for the whole protein (64). Remarkably, we observe that the normalized 
crystallographic B factors for the hPCNA-S228I IDCL are lower than those for 
hPCNA-WT (Figure 2.2d&e). This result suggests that the IDCL is actually less 
mobile in hPCNA-S228I than in WT. Despite this fact, we observe multiple 
conformations in hPCNA-S228I, demonstrating significant flexibility for this 
region. Therefore, we hypothesize that the IDCL in hPCNA-WT is especially 
flexible, but this flexibility has been hidden in static x-ray crystal structures. In 
support of this idea, recent NMR studies of hPCNA-WT demonstrated that the 
IDCL exhibits lower order parameters for the IDCL relative to the average for the 
protein, indicating substantial dynamics on the ps-ns timescale (62, 174). Finally, 
molecular dynamics simulations of hPCNA, as well as those from budding yeast 
and the archaebacterium Pyroccous furiosus, directly show that the IDCL readily 
undergoes transitions to other conformational states (175) which may have 
important implications for controlling binding of PIPs (176). These results suggest 
the novel conformations that we observe crystallographically in hPCNA-S228I 
may be accessible for hPCNA-WT. We hypothesize that alternative 
conformations of the IDCL in hPCNA-WT contribute to the specificity of PIP 
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binding and could provide a mechanism for regulation. This hypothesis will be the 
focus of future studies. 
 Several unaddressed questions remain for how PIP binding affinity is 
affected by the S228I mutation. First, is the binding of APIM-containing PIPs 
perturbed by mutation?  APIMs are found in only higher eukaryotic organisms 
(73) and have been suggested to play roles in DNA repair and damage response 
(83, 177) as well as a somewhat nebulous role in PCNA-directed kinase 
signaling and apoptosis in neutrophils (178, 179). Although the binding site for 
APIM sequences has not been identified, it has been suggested based on 
mutagenesis studies that the APIM and PIP-box motifs share the same binding 
site on PCNA (179). If this is indeed the case, APIM binding would be perturbed 
by the S228I mutation. Second, the structure of apo hPCNA-S228I illustrates that 
the IDCL would clash with the second aromatic residue in the PIP-box motif. All 
peptides tested here have an aromatic residue at this position of the motif, but 
many PIP-box sequences do not have an aromatic residue at this position (171). 
How does the S228I mutation affect binding of these motifs, if at all? Third, how 
does DNA affect binding of PIPs to hPCNA-S228I? In yeast PCNA, IDCL 
mutants that lose affinity for FEN1 in solution can partially restore binding when 
PCNA is bound to DNA (180). Thus, it remains unclear if DNA can partially 
rescue binding of FEN1 and/or RNaseH2B when it is loaded onto DNA. These 
questions will be the focus of future studies. 
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Implications for disease 
 Our results have important implications for the disease caused by the 
hypomorphic S228I mutation. The surprisingly strong alteration of the IDCL in 
hPCNA-S228I results in large deformation of the binding pocket relative to wild-
type. Clearly, this deformation does not completely abrogate binding of all PIPs 
to the mutant PCNA because a complete loss of PIP binding would be expected 
to be fatal; after all, removal of just one PIP-box interaction (from FEN1) results 
in an embryonic lethal phenotype (181). Our results suggest that some PIPs 
have large changes in binding affinity while others are relatively unperturbed, 
with a possible correlation between overall binding affinity and the extent of IDCL 
perturbation by the S228I mutation. Our data point to the malleability of the IDCL 
as an important factor in mediating binding to certain PIPs. Despite the insights 
gleaned from our structural study, it will be difficult to elucidate which PIPs are 
important for determining the phenotypic spectrum of the hPCNA-S228I disorder 
because of the large diversity and number of PIPs. To tease apart the cellular 
and molecular basis for the hPCNA-S228I disorder will require careful in vivo 
studies coupled with in vitro biochemical, biophysical and structural 
characterization of binding.  
 The phenotype of the hPCNA-S228I disorder is reminiscent of defects in 
DNA repair or DNA damage response. In patient-derived cells, defects in 
nucleotide excision repair have been observed while DNA replication appears to 
be normal (35). Therefore the S228I mutation seems to affect the DNA repair and 
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damage response pathways more than DNA replication. Analogous to the 
hPCNA-S228I disorder, the Kolodner group identified two separate mutants of 
yeast PCNA that disrupt mismatch repair but do not seem to affect DNA 
replication (182). However, these two mutations do not affect the PIP binding 
pocket, but instead interfere with the PCNA inter-subunit interactions and the 
PCNA-DNA interaction surface, respectively. Thus the sites of the mutations 
suggest that these mutations cause PCNA to dissociate from DNA prematurely, 
possibly before mismatch repair proteins can act. The S228I mutation most likely 
mediates its affect in a different manner: by disrupting binding partners rather 
than disrupting interaction with DNA. Does the S228I mutation preferentially 
disturb interactions with PIPs involved in DNA repair? Or is DNA repair simply 
more sensitive to disruption than other PCNA-mediated pathways? These 
questions will be the focus of future studies. 
 Our studies with FEN1pep reinforce the proposal by Baple et al. (35) that 
the PCNA-S228I disorder is at least partially caused by defects in NER. Previous 
pull-down experiments indicate that the human xeroderma pigmentosum XPG 
repair endonuclease exhibits reduced binding with hPCNA-S228I (35). Mutations 
in XPG cause xeroderma pigmentosum, a DNA repair disease that shares many 
symptoms with the hPCNA-S228I disorder, among them heightened UV 
sensitivity. Based on the high level of sequence similarity between the PIP-box of 
XPG and FEN1 (84), we hypothesize a similar binding defect with XPG as we 
see with FEN1pep, which results in the decreased efficiency of NER observed in 
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patient-derived cells (35). 
 In addition to a disruption in NER, our observed lack of interaction with 
RNaseH2B raises the possibility that defects in ribonucleotide excision repair 
(RER) could be a major cause of disorder. RNaseH2B is a subunit of the 
RNaseH2 enzyme that carries out RER (86, 183). RER requires FEN1, RNaseH2 
and PCNA loaded by RFC (86). Because RER is severely hindered in the 
absence of RNaseH2, RER is exquisitely sensitive to the presence and function 
of RNaseH2. In contrast FEN1 and Polδ can be replaced with Exo1 or Polε, 
respectively, illustrating the critical nature of RNaseH2B to the RER pathway 
(86). Thus, the loss of RNaseH2B interaction might be phenotypically fragile in 
that its loss has strong consequences for cellular homeostasis. Because 
mutations in RNaseH2 can give rise to a genetic disorder known as Aicardi–
Goutières Syndrome, it is well-established that RNaseH2 activity is critical for 
human health (184). Interestingly, Aicardi–Goutières Syndrome shares some 
symptoms with the disorder caused by hPCNA-S228I. In particular, both 
disorders show progressive neurodegeneration and microcephaly (abnormally 
small head size). In the initial report of the hPCNA-S228I disorder (35), both of 
these symptoms are classified as being particularly strong and prevalent. Thus, 
our results would suggest that the possibility of an RER defect contributing to the 
hPCNA-S228I  disorder. 
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CHAPTER III 
 
Investigating the cellular effects of PCNAS228I in a 
fission yeast model system 
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Introduction 
 The human sliding clamp PCNA (Proliferating cell nuclear antigen) is a 
ring-shaped protein that slides along DNA, orchestrating a variety of cellular 
processes through interactions with many protein partners (57). PCNA binding 
proteins typically use one or more of two conserved motifs, the PIP (PCNA-
interacting protein) motif or the lesser-characterized APIM motif (Alk-B homolog 2 
PCNA-interacting motif), to interact with PCNA (72, 73). Additionally, post-
translational modifications of PCNA such as ubiquitination or SUMOylation also 
modulate binding of different partners to PCNA (56). Proper modulation of 
binding partners is essential to orchestrate processes such as the DNA damage 
response. 
  A recently identified variant of the human sliding clamp, PCNAS228I, causes 
a novel disease called Ataxia telangiectasia-like disorder 2 (ATLD-2). Among the 
many functions modulated by PCNA, ATLD-2 is thought to arise from a defect in 
DNA repair, particularly nucleotide excision repair (35, 185). However, the 
molecular mechanism of this defect remains unknown. Furthermore, it is unclear 
how this mutation is tolerated given the many critical roles of PCNA.  
 Here, I describe my efforts to characterize PCNAS228I using a fission-yeast 
model system. Using standard methods for yeast genetics, I constructed a strain 
harboring pcn1-S228I as the sole copy of pcn1 and confirmed the mutation was 
integrated into the genome. I tested the effect of this mutation on multiple DNA 
repair pathways including base excision repair, nucleotide excision repair, and 
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homologous recombination repair by treating cells with various DNA damaging 
drugs at multiple concentrations. Although I attempted to distinguish between 
potential defects in DNA repair mechanisms, this strain exhibits a subtle 
phenotype in preliminary studies using a small subset of DNA damaging agents. 
However, this work produced valuable reagents and laid the foundation for 
investigating the effects of this variant in vivo. 
 
A subset of PCNA interactions in DNA repair 
 PCNA functions in almost all forms of DNA repair. PCNA helps localize 
DNA repair enzymes to sites of damage, and PCNA can help enhance enzymatic 
activities of these enzymes. I briefly highlight the role of PCNA in individual repair 
pathways below. 
Base excision repair (BER) typically fixes bases damaged by alkylation, 
oxidation, deamination, or base mismatches. BER occurs via short- or long-patch 
pathways, both of which require PCNA (31). The first step in BER is formation of 
an apurinic/apyrmidinic (AP) site. Several glycosylases, each recognizing specific 
types of damaged bases, interact with PCNA for AP formation (186, 187). In 
short-patch BER, AP endonuclease (APE1 in humans) and DNA polymerase β 
(Pol β) excise the abasic sugar and fill 1-nucletotide gaps with the aid of the 
scaffolding protein XRCC1, which binds DNA ligase III. Pol β and APE1 use PIP-
motifs to interact with PCNA (188-190), but surprisingly XRCC1 binding is not 
mediated by a PIP or APIM (191). Long-patch BER displaces 2-10 nucleotides 
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through the coordinated efforts of APE1 to cleave the abasic sugar, followed by 
PCNA-mediated DNA polymerases δ/ε and FEN1 endonuclease activity to 
synthesize a patch of the same size. All three long-patch BER enzymes use PIP 
box motifs to directly interact with PCNA, possibly simultaneously as in Okazaki 
fragment maturation (70). Thus PCNA orchestrates both the short- and long-
patch BER pathways. 
PCNA has critical roles in the nucleotide excision repair (NER) pathway 
that mediates removal and repair of bulky DNA lesions. In eukaryotes, six repair 
factors carry out NER: RPA, XPA, XPC, TFIIH, XPG, and XPFERCC1 complex 
(31). Repair occurs in three steps: 1) Damage is first recognized by XPA, RPA 
and XPC, 2) A short ~25 nucleotide oligomer is excised by the helicase activity of 
TFIIH and nuclease activities of XPG and XPFERCC1, and, 3) DNA polymerase 
ε/δ, with the aid of PCNA, synthesizes DNA to fill the gap (31). NER is dependent 
on PCNA for the DNA polymerase ε/δ-PCNA interactions, XPG-PCNA interaction 
(via PIP-motifs on polymerases ε/δ and XPG), and XPA-PCNA interaction (via an 
APIM motif on XPA) (83, 84).  
PCNA mediates the ribonucleotide excision repair (RER) pathway that 
incises misincorporated rNTPs from genomic DNA. Misincorporation of 
ribonucleotides by the replicative DNA polymerases can occur on the order of 10-
3, making it the most abundant form of DNA damage (86, 192). The presence of 
the 2’-OH on RNA makes it more susceptible to hydrolysis, creating nicks that 
would stall or collapse the replication fork. Ribonuclease H2 (RNaseH2) incises 
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the backbone 5’ to a ribonucleotide, followed by strand displacement requiring 
the coordinated efforts of DNA polymerases ε/δ and PCNA, and finally FEN1 
activity removes the flap produced by strand displacement and DNA Ligase1 
performs ligation (85, 86). The catalytic subunit of the RNaseH2 complex, 
RNaseH2B, contains a PIP-motif (61) and depends on PCNA to be localized to 
sites of damage, and PCNA also enhances its enzymatic activity (86). As 
previously stated, PCNA coordinates with DNA polymerases ε/δ, FEN1 and DNA 
ligase I via PIP-motifs as well, demonstrating PCNA is critical to carry out RER.  
 PCNA is also involved in repairing, or preventing double strand breaks 
(DSBs). Stalling and subsequent collapse of a replication fork due to template 
lesions, reactive oxidative species or ionizing radiation can all lead to DSBs (30, 
193, 194). DSBs are a particularly dangerous type of DNA damage because their 
repair can lead to gross chromosomal rearrangements or loss of genetic 
information (193). DSB are repaired primarily by two pathways, homologous 
recombination (HR) and nonhomologous end-joining (NHEJ) (195). In the HR 
pathway, the two broken ends of DNA are resected to generate 3’ single-
stranded DNA onto which the recombinase, Rad51, can load. Rad51 mediates 
strand invasion of the sister chromatid as the homologous template for DNA 
polymerase to fill in the gap (196). PCNA is required for DNA polymerases ε/δ to 
synthesize DNA post-invasion (197, 198). Unlike HR, NEHJ does not use a 
template and instead rejoins the two broken ends together with minimal 
processing. The Ku complex (Ku70/Ku80 heterodimer) initiates NHEJ repair by 
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recognizing the two broken ends, and recruits DNA dependent protein kinases 
(DNA-PKcs) as well as a specialized ligase, DNA ligase IV, to join the two ends 
(31, 199). There are no reported roles for PCNA involved in the NHEJ pathway.  
PCNA post-translational modifications allow for bypass replication or 
template switching mechanisms that help prevent DSBs. Cells use translesion 
synthesis (TLS) polymerases for bypass replication; these polymerases are error 
prone, but can synthesize through DNA lesions that stall the replicative 
polymerases ε/δ (200). In response to DNA damage such as UV radiation, the E3 
ligase Rad6/Rad18 monoubiquitinates PCNA at K164, which helps recruit TLS 
polymerases η, κ or ι to PCNA-Ub for error-prone bypass replication (87). 
Polyubiquitinated-PCNA, formed by the combined actions of the  Rad6/Rad18 
and Rad5 E3 ligases, mediates the template-switching mechanism for error-free 
bypass replication (87). Finally, SUMOylated-PCNA at either K164 (as a primary 
site) or K127 (as a secondary site) by Ubc9/Siz1 is thought to prevent HR by 
recruiting the anti-recombinogenic Srs2 helicase (87, 90, 201, 202). 
With a complicated role in DNA repair, it remains unclear which DNA 
repair pathway or pathways are affected by the S228I variant. Although 
preliminary experiments suggest an NER defect (35), other repair mechanisms 
may be perturbed by the mutation as well. In support of this hypothesis, ATLD-2 
patients exhibit symptoms similar to diseases caused by disruption of DSB repair 
as well as NER disorders (35).  
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Our previous work (Chapter II) on human PCNAS228I revealed the mutation 
reduces binding of three peptides from PCNA interacting partners: p21CIP1, 
FEN1, and RNaseH2B (63). p21CIP1 is one of the tightest known binders to PCNA 
and is critical for cell cycle regulation. FEN1 endonuclease cleaves “flap” 
structures on DNA, and has essential roles for DNA damage repair and for 
Okazaki fragment maturation. Finally, RNaseH2B is part of the RNaseH2 
complex that degrades transcription-related R-loops, and ribonucleotides 
improperly incorporated during DNA replication (61). While all three of these 
peptide-PCNAS228I interactions were reduced compared to WT PCNA, FEN1 and 
RNaseH2B were the most affected (63). The loss-of-interaction with FEN1 and 
RNaseH2B supports the hypothesis that PCNAS228I disrupts DNA repair while 
leaving other PCNA functions intact. However, neither study of ATLD2 (35, 63) 
have not revealed which specific DNA repair pathways are affected by this 
mutant. 
 
Rationale for a yeast model system for ATLD2 
 In order to study the cellular effects of the PCNAS228I mutant, we selected 
the fission yeast Schizosaccharomyces pombe as our model system. There is a 
relatively high overall sequence similarity between S. pombe pcn1 and human 
PCNA (52% identical, Figure 3.1a), while S. cerevisiae PCNA is less well 
conserved (36% identical, Figure 3.1b) and therefore was not chosen for further 
study. Additionally, the site of the mutation, S228I, as well as key residues 
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affected by the mutation (63) are conserved in S. pombe (Figure 3.1). Finally, 
the relevant DNA repair pathways are conserved in S. pombe (203).  
 There is a wide assortment of small molecules that have been used in 
fission yeast to tease apart defects in DNA repair pathways. Because of the 
suggestion that S228I particularly effects excision repair, I selected small 
molecules that especially target these pathways. 4-nitroquinoline 1-oxide (4NQO) 
induces adducts on guanine and adenine, and can also cause purine to 
pyrimidine transversions (204). This type of damage induces the NER pathway. 
Methyl methanesulfonate (MMS) is an alkylating agent, and typically methylates 
guanine and adenine (205). These lesions can be repaired by excision repair, or 
if they lead to stalled replication forks, can require repair by HR (205-207). 
Hydroxyurea (HU) inhibits ribonucleotide reductase, leading to decreased dNTP 
pools. In checkpoint deficient backgrounds, decreased dNTP pools ultimately 
leads to fork collapse from stalled forks (208-210). HR and NHEJ repair this 
damage (210). Finally, ultraviolet (UV) light induces thymidine dimers, 
cyclobutane pyrimidine dimers (CPDs), and (6-4) pyrimidine pyrimidones (6-4 
PPs) repaired by NER, or bypassed by using TLS polymerases (211). Using 
these DNA damage agents allows us to probe the affects of the PCNAS228I 
variant on specific repair pathways.  
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Materials and Methods 
Plasmid construction 
 Genomic DNA was isolated from yFS105 (WT) cells using standard 
phenol-cholorform extraction (212). A fragment containing pcn1, with 1kb 
upstream and 0.5kb downstream flanking regions was PCR amplified from 
genomic S. pombe DNA using primers with the sequence 5’-
CGGGTACCCATGGAATACTCGAAACCCGG-3’ and 5’- 
GCGGATCCGCTCACAGAGTTGTGTCTAG-3’. This fragment was digested with 
Kpn1 and BamHI and cloned into the Kpn1 site of yFS117 target vector. 
Integration into the vector was confirmed through sequence analysis. Site-
directed mutagenesis was performed using a protocol similar to QuikChange 
(147) using WT-pcn1 in yFS117 and primers with the sequence 5’- 
GAGTCACACTTatcATGAGCAATGATGTTCCACTTCTTGTGG-3’ and 5’- 
CATTGCTCATgatAAGTGTGACTCGGGTAGCTAAAGGAGTAGC-3’. The codon 
for isoleucine created a BspHI restriction endonuclease cleavage site within the 
modified pcn1 gene, which was later used for diagnostic PCR (see below). 
Enzymes were purchased from New England BioLabs. Oligonucleotides were 
purchased from IDT.  
 
Cell culture and preparation of DNA damaging agents 
 Cells were cultured using standard techniques (212). For rich media, cells 
were cultured in yeast extract plus supplements (YES; 0.5% w/v yeast extract, 
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3% w/v glucose, plus supplements of 225mg/L each of adenine, histidine, 
leucine, and uracil). For transformation selection, cells were cultured in 
Edinborough minimal media lacking uracil (EMM2-URA). To induce sporulation, 
diploids were patched onto malt extract plates (ME; 3% w/v malt extract plus 
supplements).  
 DNA-damaging agents were prepared by the following: 5mM stock 
solutions of 4NQO (Sigma-Aldrich N-8141) were solubilized in DMSO and stored 
at -20°C. 1M stock of hydroxyurea (Sigma-Aldrich H8627) was solubilized in 
sterile water and prepared fresh.  99% MMS (Sigma-Aldrich 129925) was diluted 
to a working stock concentration in water. DNA-damaging agents were added to 
cooled autoclaved YES media at specified concentrations in an Erlenmeyer flask 
and mixed prior to pouring plates. Fresh plates were prepared for each 
experiment and used within 24 hours. For UV-exposure, cells were spotted on 
YES plates and exposed to short-wavelength (254nm) UV using a Stratalinker 
(Stratagene).  
 
Strain construction 
 The strains used are listed in Table 1. yNR45, yFS104, yFS105, and 
yFS189 were kindly provided by Dr. Nicholas Rhind. A strain containing pcn1-
S228I as the sole copy of pcn1 was constructed using a pop-in/pop-out strategy 
(213). The target vector, pcn1-S228I in yFS117 was linearized with Pst1, and 
transformed into the WT diploid yNR45 using standard lithium acetate protocols 
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(212, 214). Cells were plated on EMM2-URA select for transformants and 
incubated at 30°C. Single colonies were restreaked onto EMM2-URA+adenine to 
reduce false positives. Single colonies were patched onto ME plates to induce 
sporulation and incubated for 3-4 days at 25°C. After confirming crescent shaped 
tetrads containing 4 spores under a 40x light microscope, a single colony was 
resuspended in sterile water by toothpick, and the slurry was transferred onto a 
thin-layer YES plate in a horizontal line. Using a Zeiss Axioskop dissecting 
microscope, tetrads with uniform spores were moved 5mm away from the slurry 
streak. Plates were incubated at 37°C for 2-4 hours to allow the asci wall to break 
down before dissection. Plates were incubated at 25°C for 3-5 days until spores 
grew. Cells were replica-plated onto YES, EMM2-URA, and EMM2-URA 
supplemented with 1mg/mL 5’-fluroorotic acid (5’-FOA). 5’-FOA selects for cells 
in which the ura4 gene has been lost (pop-out) (215). FOAR colonies were re-
streaked an additional time for single colonies to ensure a homologous 
population. 
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Table 3.1: List of S. pombe strains used in this study. 
 
Strain confirmation using diagnostic PCR 
 To confirm pcn1-S228I was integrated into the genome, a 600-bp 
fragment containing the site of the mutation was PCR amplified using primers 
with the sequence 5’-GCCGAATTTCAACGCATTAC-3’ and 5’-
CAAGCTACAGCAGATGATTACGA-3’. Genomic DNA was isolated from single 
FOAS colonies using a standard phenol-chloroform extraction (212). This PCR 
fragment was digested with BspHI and visualized on a 2% agarose gel. Cells 
which were successfully integrated with pcn1-S228I show two digested bands 
sized ~350bp and ~260bp. WT cells show a single band sized ~600bp. 
 Full-length pcn1-S228I, including 1kb upstream and 0.5kb downstream 
from the gene, was PCR amplified from cells which were positive for BspHI 
digest using primers with the sequence 5’-
CGGGTACCCATGGAATACTCGAAACCCGG-3’ and 5’- 
GCGGATCCGCTCACAGAGTTGTGTCTAG-3’. This ~2.7 kb fragment was sent 
for sequencing (Genewiz) to confirm the inserted mutation, and that no additional 
Strain Phenotype Genotype Source
yNR45 WT (diploid)
h+/h- leu1-32/leu1-32 ura4-D18/ura4-
D18 ade6-210/ade6-216 his7-366/his7-
366
N. Rhind
yFS104 WT (haploid, h+ ) h+ leu1-32 ura4-D18 N. Rhind
yFS105 WT (haploid, h-) h- leu1-32 ura4-D18 N. Rhind
yFS189 rad3ǻ h- leu1-32 ura4-? ade6-704 rad3::ura4 N. Rhind
yBK06 pcn1-S228I h-? leu1-32 ura4-D18 ade6-? his7-366 pcn1-228 This study
yBK07 pcn1-S228I h-? leu1-32 ura4-D18 ade6-? his7-366 pcn1-228 This study
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mutations were introduced to the gene. Additional primers with the sequences 5’- 
CCAAATTCAATACCTCAGGTG-3’, 5’-GCCGAATTTCAACGCATTAC-3’, and 5’-
CAAGCTACAGCAGATGATTACGA-3’ were used for full sequencing coverage of 
the pcn1 gene and flanking regions.  
 
Serial dilution growth assay 
 Strains used in the serial dilution growth assay were grown in YES media 
overnight to saturation at 25°C (for initial temperature sensitivity studies) or 30°C 
(for all subsequent experiments). Cultures were diluted in YES to OD600 = 0.4 
and allowed to grow 4 hours to an OD600 of ~ 1.0. 1.0 OD600 of each culture was 
spun down and resuspended in 250µL sterile water. 5-fold serial dilutions of 
culture were prepared using sterile water and transferred to a sterile 96-well 
plate. A 48-pin-replica plater for 96-well plate (Sigma-Aldrich R23823) was flame 
sterilized using 100% ethanol. Cells were transferred using the replica plater to 
YES agar plates, or YES+DNA-damaging agent plates. Plates were allowed to 
dry for 15 minutes before transferring to incubators at desired temperature (25°C, 
30°C, 35°C, 37°C for initial temperature sensitivity studies; 30°C for all 
subsequent experiments). Plates were imaged on a Fujifilm LAS3000 (GE) after 
72hrs.  
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Results 
pcn1-S228I is viable and not temperature sensitive 
 Using a pop-in/pop-out allele replacement strategy, I successfully 
constructed a haploid strain of pcn1-S228I. Briefly, a target vector lacking an 
autonomously replication sequence (ARS) containing ura4+ as an auxotrophic 
marker was constructed containing pcn1-S228I and transformed into a diploid 
WT parent strain. The diploid parent strain was chosen because pcn1 is an 
essential gene and we wanted to avoid viability issues in the case that pcn1-
S228I was a lethal mutation.  
The “pop-in” portion of the strategy takes advantage of the fact the target 
vector lacks an origin of replication, and ura4+ colonies represent a successful 
integration of the target vector into the genome by homologous recombination 
(Figure 3.2a). The pop-in event results in an unstable intermediate in which a 
tandem duplication of pcn1 exists in the genome: a WT copy and a copy 
harboring S228I (Figure 3.2b).  
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The “pop-out” recombination event takes advantage of the negative 
selection against ura4+ using the drug 5’-fluoroorotic acid (5’-FOA) (215). Pop-out 
events produce two outcomes, depending on which side of the modified allele 
recombination takes place. In the case of pcn1-S228I, recombination upstream of 
the mutation results in a WT copy of pcn1 left in the genome (Figure 3.2c). 
Recombination downstream of the mutation results in pcn1-S228I left in the 
genome (Figure 3.2d). Cells were sporulated and dissected prior to pop-out. 
Successful tetrad dissection resulted in 4 viable spores on YES plates, which 
were plated on media selecting for ura4+, followed by FOA selection. The viable 
FOAR cells after pop-out indicate that pcn1-S228I is viable as the sole copy of 
pcn1.  
To confirm pcn1-S228I remained in the genome, genomic DNA was 
isolated from colonies that were FOAR. A small fragment of pcn1 was PCR 
amplified from genomic DNA and digested with BspHI. WT cells lack a BspHI 
site, whereas pcn1-S228I cells are susceptible to digest. I confirmed two strain 
isolates of pcn1-S228I by BspHI digest (Figure 3.3). Full-length pcn1-S228I was 
PCR amplified from genomic DNA from both strain isolates. Sequencing this 
fragment confirmed the S228I mutation, and also confirmed no additional 
mutations were introduced to the gene, or regulatory elements upstream and 
downstream of pcn1.  
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Figure 3.3: Restriction endonuclease genotyping confirms mutation 
integration into the genome. Genomic DNA was prepped from candidate 
strains (yBK06, yBK07) and WT controls (yFS105, yNR45). A 600bp fragment 
flanking the mutation site was amplified from gDNA, digested with BspHI and run 
on a 2% agarose gel. Candidate strains were positive for the digestion (~350bp 
and 260bp products), indicating the S228I-allele was integrated into the genome, 
whereas WT strains were negative for the digest. As an additional control, the 
targeting vector (confirmed via sequencing) used for the ‘pop-in, pop-out’ 
strategy (pFS117) was also BspHI treated: Mutant plasmid contains an additional 
cut site (approximately 2kb) compared to the WT plasmid. 
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 Using a serial dilution growth assay, I confirmed that the two pcn1-S228I 
strains (yBK06 and yBK07, respectively) were viable on YES media and that 
growth is comparable to WT cells. After incubating pcn1-S228I at various 
temperatures, pcn1-S228I shows no temperature sensitivity and grows similarly 
to WT (Figure 3.4). Given the effect of the S228I variant on PCNA function (35, 
63), I next wanted to investigate any responses pcn1-S228I has to DNA 
damaging agents.  
 
Figure 3.4: pcn1-S228I is viable and not temperature sensitive. A 5-
fold serial dilution of S.pombe strains were plated on YES and grown at indicated 
temperatures to assay for strain viability. Two WT strains (yFS104 and yFS105) 
serve as controls. rad3Δ serves as a negative control in the following DNA 
damage response experiments. The two isolated pcn1-S228I strains, yBK06 and 
yBK07, are viable, not temperature sensitive, and appear to grow similar to WT. 
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pcn1-S228I displays a subtle phenotype in response to select DNA damaging 
agents 
 Based on the results of Baple, et al. (35), we hypothesized pcn1-S228I 
would be sensitive to DNA damaging agents, particularly agents that induced the 
NER pathway. To test this hypothesis, yBK06 and yBK07 cells were treated with 
the DNA damaging agents MMS, 4NQO, HU, and UV light. WT strains yNR104 
and yNR105 were included as a control. A strain in which the checkpoint kinase 
Rad3 was deleted served as a positive control, as rad3Δ would be sensitive to all 
damaging agents. Indeed, rad3Δ was inviable in the presence of all agents 
tested (Figures 3.5-3.8). yBK06 and yBK07 showed weak growth defects at high 
concentrations of MMS and HU (Figures 3.5, 3.6). These strains did not show 
any growth defects in response to 4NQO or UV light, or low concentrations of 
MMS or HU (Figures 3.7, 3.8).  
 
Figure 3.5: pcn1-S228I is sensitive to high concentrations of hydroxyurea. 
A 5-fold serial dilution of S. pombe strains were plated on YES ± hydroxyurea. 
WT yFS105 and rad3Δ serves as controls. The two isolated pcn1-S228I strains, 
yBK06 and yBK07, show weak growth defects compared to WT in response to 
>5mM hydroxyurea. 
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Figure 3.6: pcn1-S228I is sensitive to high concentrations of MMS.  
5-fold serial dilution of S. pombe strains were plated on YES ± MMS. WT yFS105 
and rad3Δ serves as controls. The two isolated pcn1-S228I strains, yBK06 and 
yBK07, show weak growth defects compared to WT in response to >0.0075% 
MMS. 
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Figure 3.7: pcn1-S228I is unaffected by 4NQO. 
5-fold serial dilutions of S. pombe strains were plated on YES ± 4NQO. WT 
yFS105 and rad3Δ serves as controls. The two isolated pcn1-S228I strains, 
yBK06 and yBK07, show no growth defects compared to WT in response to any 
dose of 4NQO. 
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Figure 3.8: pcn1-S228I is unaffected by UV light. 
5-fold serial dilution of S. pombe strains were plated on YES and exposed to 
254-nm UV light at indicated doses. WT yFS105 and rad3Δ serves as controls. 
The two isolated pcn1-S228I strains, yBK06 and yBK07, show no growth defects 
compared to WT in response to UV light. 
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Discussion 
 I generated a fission yeast model system to further investigate the cellular 
effects of pcn1-S228I. This mutation is viable as the sole copy of pcn1 (Figure 
3.4, and there were subtle growth defects in response to DNA damaging agents 
(Figures 3.5, 3.6). pcn1-S228I cells grew similarly to WT where NER inducing 
damaging agents were introduced (UV light and 4NQO) suggesting NER is not 
affected by the mutation (Figures 3.7, 3.8).  
 S. pombe has an alternate excision pathway to repair UV damage (216, 
217) which could potentially compensate for the loss of function associated with 
the PCNA S228I mutation. The UV damage excision repair pathway (UVER) 
uses an endonuclease, UVDE, encoded by the uvde gene, to excise both the 
major types of UV induced lesions, CPDs and 6-4 photoproducts, using the help 
of rad2, the FEN1 homolog in S. pombe (218, 219). UVDE can also nick AP 
sites, acting as an AP endonuclease (220). If pcn1-S228I does induce NER, 
perhaps the lack of a phenotype seen in response to UV light or 4NQO is 
indicative of a compensatory mechanism where the UVER pathway takes over. It 
is possible PCNA may mediate UVER through rad2/FEN1, but to date, there are 
no reported roles of pcn1 acting in the alternate UVER pathway. Repeating these 
experiments in an uvde- deficient strain would test UVER compensates for the 
S228I variant.  
 The weak phenotype in response to high concentrations of MMS and HU 
may be attributed to a defect in HR. Both MMS and HU stall replication forks, 
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which can lead to fork collapse, requiring repair by HR. This requirement 
suggests pcn1-S228I cannot be modified by ubiquitin or SUMO because these 
PCNA modifications are necessary to prevent folk collapse by initiating bypass 
replication or template-switching. This could be tested by immunoprecipitating 
pcn1 and measuring modifications using Ub- or SUMO-specific antibodies.  
 The HU phenotype may also reflect PCNA’s role in the RER pathway. HU 
inhibits ribonucleotide reductase, depleting the dNTP pool (206, 210). 
Consequentially, the ratios of rNTP/dNTP increase, raising the possibility of 
ribonucleotide incorporation into DNA and triggering the RER response. A similar 
mechanism was observed in studies with human DNA polymerase µ; changing 
ratios of rNTP/dNTP lead to increased rNTP incorporation (221). Our previous 
work shows PCNAS228I abolishes interaction with RNaseH2B, a critical factor in 
RER. Mutations in RNaseH cause Aicardi Goutieres syndrome which shares 
clinical similarities to patients with ATLD-2 (184). Therefore we proposed a loss-
of-interaction induced by the S228I mutation may cause an RER defect that 
contributes to ATLD-2. The weak phenotype pcn1-S228I shows in response to 
HU supports this putative defect in RER. A defect in RER leading to increased 
rNTP incorporation can be assessed from alkali-treated genomic DNA from pcn1-
S228I; if pcn1-S228I perturbs RER, it should be more highly sensitive to alkali 
treatment than WT and display alkaline gel electrophoresis mobility similar to a 
strain with a deletion in RNase H (S. pombe gene rnh1) (222, 223).  
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Disruption of DNA damage checkpoints could also explain the weak 
phenotype of pcn1-S228I. These experiments were not performed under 
conditions of cell cycle control, so we cannot reasonably speculate if the weak 
phenotype is due to a defect in DNA damage checkpoints unless repeated under 
synchronized conditions. However, ataxia telangiectasia (AT), which shares 
clinical phenotypes with ATLD-2, is caused by mutations in ATM, a master 
checkpoint kinase (224). ATM interacts with PCNA, despite lacking a PIP-motif 
(225). If pcn1-S228I disrupts DNA damage checkpoints, it could be due to a loss 
of interaction with ATM.  
A compensatory mechanism may alleviate deleterious effects caused by a 
loss of interaction between the S228I mutant and ATM. An alternative clamp 
loader, Rad17-RFC, and the alternative sliding clamp, Rad9-Rad1-Hus1 complex 
(9-1-1), also function during checkpoint responses (226). 9-1-1 also interacts with 
the damage sensor kinases ATM and ATR (Tel1 and Rad3 in S. pombe, 
respectively) in response to DNA damage (227). The alternative clamp, 9-1-1, 
which is functionally and structurally similar to PCNA (226, 228, 229), could 
compensate for pcn1-S228I, which would explain the weak phenotype in 
response to DNA damaging agents. If this compensatory mechanism is 
responsible for the weak phenotype then knocking out the 9-1-1 clamp in both 
WT and pcn1-S228I backgrounds and synchronizing cells prior to DNA damage 
should result in a more severe phenotype. 
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 The subtle nuances of exactly how DNA damage response pathways are 
affected by the S228I mutation require further investigation. This fission yeast 
strain will be a valuable reagent to use in synthetic lethality screens to identify 
which pathways are affected by this mutation. Other model systems could also 
be considered for investigating the cellular effects of this mutant, particularly in 
vitro cell culture systems using cell lines derived from affected patients, or 
Drosophila melanogaster S2-cell lines due to the high homology shared between 
D. melanogaster mus209 and human PCNA (71% identical). However, the 
tractability of an in vivo yeast system, as well as the reagents generated here will 
be useful to further understand the mechanisms that are the underlying cause of 
ATLD-2, as well as further elucidate the vast network of PCNA-interactions.  
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CHAPTER IV 
 
Mechanisms for primer/template binding and ATP 
hydrolysis in the DNA sliding clamp loader   
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Introduction 
The sliding clamp loader is required for DNA replication 
 Most DNA polymerases require a sliding clamp (PCNA), a ring shaped 
protein that prevents polymerase dissociation from DNA, in order to achieve 
high-speed, accurate DNA replication. The clamp, an essential component of the 
replication fork, increases the processivity of polymerases by several orders of 
magnitude (4, 13). Because the clamp is a closed ring, it must be actively loaded 
onto primed DNA by the sliding clamp loader (51, 99, 100). The sliding clamp 
loader is a member of the AAA+ (ATPase associated with various cellular 
activities) family of ATPases (106), and couples primer/template binding and 
subsequent ATP hydrolysis to clamp closure and clamp loader ejection (Figure 
4.1a).  
 Sliding clamp loaders are evolutionarily conserved, and share an overall 
similar architecture across all branches of life (99, 100). Unlike related hexameric 
AAA+ ATPases, the clamp loader is a spiral-shaped pentamer that possesses a 
gap between the first and fifth subunit where the missing sixth subunit would be 
(101, 103, 116). Viral clamp loaders contain 2 proteins in a 4:1 stoichiometry, 
bacterial clamp loaders contain 3 proteins in a 3:1:1 stoichiometry, and 
eukaryotic clamp loaders are heteropentamers. A universal naming scheme A-E 
describes the position of each subunit, starting with the subunit at the open 
interface and proceeding counter-clockwise around the ring (102) (Figure 4.1b). 
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 Elegant structural and biochemical studies have provided a detailed 
understanding of the clamp loader reaction (103, 116) (Figure 4.2). In the 
absence of ATP, the clamp loader cannot organize into a spiral shape (101). 
Upon ATP-binding, the clamp loader undergoes a conformational change to 
adopt spiral conformation that allows for clamp binding and opening (101, 102). 
The clamp loader and open clamp match the helical symmetry of DNA, allowing 
primer/template binding (103). Because the clamp opening is not wide enough to 
accommodate dsDNA (103, 121), it is hypothesized that the single stranded 5’-
template overhang binds first, allowing the rest of the primer/template to 
corkscrew up into the clamp:clamp loader complex. DNA binding promotes ATP 
hydrolysis, causing clamp closure (103, 116). ATP hydrolysis is thought to initiate 
in the B-subunit (103). Subsequent ATP hydrolysis in the C- and D-subunits 
promotes clamp loader ejection. Recent crystal structures helped reveal an 
unprecedented view of the clamp loader reaction, it is still not understood how 
different nucleic acid duplexes modulate the energetics of binding, nor how ATP 
hydrolysis is coordinated within the context of the AAA+ spiral. 
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Figure 4.1: Clamp loaders and sliding clamps.  
(A) Clamp-loading reaction. The clamp loader has low affinity for both clamp and 
primer/template DNA in the absence of ATP. Upon binding ATP, the clamp 
loader can bind the clamp and open it. The binding of primer/template DNA 
activates ATP hydrolysis, leading to ejection of the clamp loader. (B) Three 
classes of clamp loaders. Bacterial clamp loaders are pentamers consisting of 
three proteins: δ (A position), γ (B, C, and D positions), and δ’ (E position). 
Eukaryotic clamp loaders (RFCs) consist of five different proteins, with the A 
subunit containing an A ́ domain that bridges the gap between the A and E AAA+ 
modules. The T4 bacteriophage clamp loader consists of two proteins: gp44 (the 
B, C, D, and E subunits) and gp62 (the A subunit). (103) 
 
Reprinted with permission from AAAS. License number 3873220605050 
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Figure 4.2: A detailed mechanism for the clamp loading reaction.  
The reaction cycle for the T4 clamp loader is shown as a schematic diagram. (1) 
In the absence of ATP, the clamp loader AAA+ modules cannot organize into a 
spiral shape. (2) Upon ATP binding, the AAA+ modules form a spiral that can 
bind and open the clamp. (3) Primer/template DNA must thread through the gaps 
between the clamp subunits I and III and the clamp loader A and A ́ domains. (4) 
Upon DNA binding in the interior chamber of the clamp loader, ATP hydrolysis is 
activated, most likely through flipping of the switch residue and release of the 
Walker B glutamate. (5) ATP hydrolysis at the B subunit breaks the interface at 
the AAA+ modules of the B and C subunits and allows closure of the clamp 
around primer/template DNA. Further ATP hydrolyses at the C and D subunits 
dissolve the symmetric spiral of AAA+ modules, thus ejecting the clamp loader 
because the recognition of DNA and the clamp is broken. The clamp is now 
loaded onto primer/template DNA, and the clamp loader is free to recycle for 
another round of clamp loading. 
Intermediates (1), (4), and (5) are based on crystal structures from Jeruzalmi et 
al. 2001, Kelch et al. 2011, and Kelch et al. 2011, respectively. (101, 103) 
Reprinted with permission from AAAS. License number 3873220605050 
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How does the clamp loader engage at primer/template junctions? 
 Because DNA polymerases cannot synthesize DNA de novo, they require 
a short primer to be synthesized at the replication fork by primases (22). 
Primases synthesize RNA-containing primers at the replication fork and their 
actions are required at the beginning of each Okazaki fragment on the lagging 
strand. In bacteria, archaeal and viruses, this RNA/DNA primer/template is the 
substrate for clamp loader action (22, 230, 231). Despite the primer/template 
consisting of a RNA/DNA duplex, all previous structural studies and most 
biochemical experiments investigating the clamp loader:primer/template 
interaction have used a primer/template consisting solely of DNA. The lack of 
data utilizing a RNA/DNA hybrid duplex demonstrates a gap in understanding the 
clamp loader reaction. 
 The significance of using RNA/DNA hybrids during replication and 
Okazaki fragment maturation requires that the clamp and clamp loader must 
accommodate both A- and B-form DNA. Double-stranded DNA predominantly 
exists as B-form in solution, while dsRNA and RNA/DNA duplexes are A-form 
(29, 125, 232, 233). Ribonucleotides cannot adopt B-form because the 2’-OH 
would clash with the 3’-OH in the B-form conformation (29). Indeed, the 
introduction of even a single ribonucleotide in a DNA strand converts B-DNA to 
A-DNA (234). Based on the several crystal structures of the sliding clamp from 
various organisms, the width of its inner pore is approximately 34Å, wide enough 
to accommodate both A- and B-forms (43, 48, 49). 
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the E. coli clamp loader bound to primer/template DNA (103, 116). Both 
structures show the primer strand lacks significant contacts to the clamp loader, 
suggesting that the loader can accommodate either DNA or RNA primer (Figure 
4.3). The strongest interaction between the primer strand and the clamp loader is 
at residue S112 in the T4 gp44 B-subunit, but this interaction is not found in all 
subunits within the assembly (Figure 4.4). The clamp loader also induces a 
conformational change in the bound primer/template DNA from B-form to nearly 
A-form (Figure 4.5), again suggesting an RNA primer could be accommodated 
(103, 116). A model of ideal B-form primer/template DNA into the T4 clamp 
loader structure revealed there would be steric clashes between the primer 
strand, and S112 within B-E subunits of the clamp loader (103). Additionally, 
modeling an A-form RNA/DNA hybrid into the E. coli clamp loader structure 
showed no clashes (116). Because RNA/DNA hybrids are already A-form in 
solution, these primer/template junctions would not need to reorganize upon 
clamp loader binding. In contrast, B-form DNA-DNA duplexes would be expected 
to use some of the binding energy to reorganize the double-helix into A-form. 
Therefore, we hypothesize a RNA/DNA primer/template interacts more favorably 
with the clamp loader than a DNA/DNA primer/template. 
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How does ATP hydrolysis occur around the clamp loader spiral? 
 Primer/template binding is directly coupled to ATP hydrolysis (118, 126, 
127). An important residue responsible for initiating ATP hydrolysis is a 
conserved glutamate in the Walker B motif, which is common to all AAA-
ATPases (106). This catalytic glutamate orients a water molecule for nucleophilic 
attack on the γ-phosphate of ATP. However, prior to primer/template binding, the 
Walker B catalytic glutamate is held in an inactive conformation by a conserved 
basic “switch” residue (102, 103, 126). This switch residue, Lys80 in T4, interacts 
with the backbone of the catalytic glutamate and orients it away from the catalytic 
water, preventing ATP hydrolysis. Upon primer/template DNA binding, the switch 
residue changes conformation to directly contact the phosphate backbone of the 
template strand, releasing the glutamate to assume a conformation competent to 
catalyze ATP hydrolysis (103).  
 A crystal structure of the T4 clamp loader in a partially hydrolyzed state 
suggested a mechanism by which ATP hydrolysis occurs around the ring (103). 
This structure shows only the B-subunit in a post-hydrolysis state, and as a 
result, the clamp is closed (Figure 4.6). The ATP hydrolyzed B-subunit moves 
away from its neighboring C-subunit, creating space for a similar conformational 
change upon ATP hydrolysis in the C-subunit. Therefore, we hypothesize that 
ATP hydrolysis occurs sequentially around the spiral, starting from the B subunit. 
Evidence for a sequential ATP hydrolysis mechanism has been seen in other 
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Approach 
In this chapter, I attempt to understand two important aspects of the clamp 
loader reaction: 1) how nucleic acid composition of the primer template junction 
modulates clamp loader binding and catalysis, and 2) whether the ATP 
hydrolysis mechanism is sequential or random for subunits within the clamp 
loader spiral. While my crystallographic attempts were unsuccessful, I generated 
biochemical data to partially address both of these questions using a combination 
of in vitro assays. This data will be useful for further understanding the clamp 
loader reaction, as well as serve as a model for additional members of the AAA+ 
family.  
 
Materials and Methods  
Mutant T4 clamp loader constructs: 
 Site-directed mutagenesis for T57A was performed using a protocol 
similar to QuikChange (147) using primers with the sequence 5’— 
GAACAGGTAAAgcaACTGTAGCAAAAGCATTATGTCATGATGTAAATGC 
—3’ and 5’— 
GCTTTTGCTACAGTtgcTTTACCTGTTCCTGGAGAAGGAGAATGAAG 
—3’.  
 
Mutant T4 clamp loader expression:  
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 Constructs harboring S112A, S112K or T57A mutations in gp44 were 
transformed into BLR(DE3) cells, and maintained in the presence of kanamycin 
(Kan). Single colonies were inoculated in 100mL LB+Kan and grew overnight at 
37°C. 10mL of saturated culture was inoculated into TB+Kan and incubated at 
37°C until an OD600 of ~0.8 was reached. Cultures were moved to 4°C for 30 
minutes before being induced with 1x Isopropyl β-D-1-thiogalactopyranoside 
(IPTG), and transferred to 18°C overnight. Cultures were pelleted at 5000 rpm for 
15 minutes at 4°C. Pellets were resuspended in 25mL of Buffer A (50mM Tris pH 
7.5, 20mM imidazole, 250mM NaCl, 10% glycerol, 5mM β-mercaptoethanol) 
before being flash frozen in liquid nitrogen and stored at -80°C.  
 
T4 clamp loader purification: 
 Pellets were thawed in water and resuspended in Buffer A before being 
passed through a cell disruptor at 80 psi (Microfluidics Corporation). Lysates 
were spun at 15,000 rpm, for 40 minutes at 4°C. Cleared lysate was pre-filtered 
by syringe using a 5µm filter, followed by vacuum filtration using a 0.45µm filter. 
Filtered lysates were applied to three tandem HisTrap 5mL affinity columns (GE) 
pre-equilibrated in Buffer A. Loaded columns were washed with Buffer A, and 
protein was eluted in 100% Buffer B (50mM Tris pH 7.5, 500mM imidazole, 
250mM NaCl, 10% glycerol, 5mM β-mercaptoethanol). Fractions containing 
gp44/gp22 were pooled and dialyzed overnight in Buffer HepA (20mM Tris pH 
7.5, 150mM NaCl, 10% glycerol, 2mM 1,4-Dithiothreitol (DTT)) containing 
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PreScission protease at 4°C. Dialysates were filtered using a 0.45µm filter before 
being loaded onto a 5mL HiTrap-SP column (GE), followed by three tandem 
Heparin 5mL affinity columns (GE) pre-equilibrated in Buffer HepA. After loading 
protein, the SP column was removed. HepA columns were washed with 50mL of 
Buffer HepA. Protein was eluted in a gradient of Buffer HepB (20mM Tris, pH 7.5, 
1 M NaCl, 10% glycerol, 2mM DTT); gp44/gp62 eluted between 10-25% Buffer 
HepB. Fractions containing gp44/62 were pooled and concentrated using an 
Amicon 10K MWCO spin concentrator to ~5mL before being injected onto a 
Superdex 200 (GE) gel filtration column pre-equilibrated in gel filtration buffer 
(20mM HEPEs, pH 7.5, 150mM NaCl, 10mM DTT). Fractions containing 
gp44/gp62 were pooled and concentrated using Amicon 10K MWCO spin 
concentrator to 60-70mg/mL. Aliquots were flash frozen in liquid nitrogen before 
being stored at -80°C.  
 
DNA anisotropy assays:  
 Anisotropy assays to assess primer/template binding were performed at 
20°C. Reagents were added to the specified concentration to a single cuvette in 
the following order: Buffer A (50mM Tris, pH7.5, 250mM potassium glutamate, 
2mM DTT, 10% v/v glycerol), 1 mM ADP, 10 mM NaF, 2 mM BeCl2, 1 mM MgCl2, 
100 nM 20d5p10-TAMRA primer/template (20d5p10 indicates a 20 bp duplex, 
followed by 10nt 5’ overhang), and 2 µM gp45. The clamp loader gp44/gp62 was 
added last and titrated across 0-4 µM such that the total protein concentration 
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only varied by less than 5%. Primer/templates having a 20 base pair double-
stranded duplex and a 10 nucleotide overhang were constructed using 
oliognucleotides with the sequences 5’—
TTTTTTTTTTTATGTACTCGTAGTGTCTGC-3’ (template) and either 5’—
GCAGACACTACGAGTACATA–3’ (DNA primer) or 5’ 
GCAGACACUACGAGUACAUA –3’ (RNA primer). Primer/templates were 
annealed by heating to 95°C, followed by a slow cooling (>3 hours) to room 
temperature. A Fluoromax-4 fluorimeter (Horibal Scientific) equipped with a 
Peltier-temperature controlled sample chamber was set up for a single point 
anisotropy method, excitation at 550nm and emission at 580nm, using slit-widths 
of 3.5nm and 9nm, respectively, and an integration time of 5 seconds. Anistropy 
was calculated from using the equation (III - I⊥)/(III + 2I⊥). Data were fit to a tight-
binding equation using the tight-binding equation 
𝜃 = !!!!!!!!± (!!!!!!!!)!!!(!!!!)!!! 𝐵!"#  where θ= fraction bound, 𝐶!= total 
clamp loader concentration, 𝐷!= total DNA/DNA concentration (100nM), 𝐾! is 
clamp loader concentration that yields half-maximum bound, and 𝐵!"# is the 
change in amplitude.  
 
Enzyme-coupled ATPase assay:  
Coupled enzyme assays (238) were performed at room temperature using 
the following concentrations (unless otherwise noted): 6 U/mL pyruvate kinase, 6 
U/mL lactate dehydrogenase, 1 mM phosphoenolpyruvate, 340 µM NADH, 50 
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mM Tris (pH 7.5), 500 µM Tris(2-carboxyethyl) phosphine, 100 mM potassium 
glutamate, 5 mM magnesium chloride, 0.5 µM gp45, and 7.5nM gp44/gp62.  
For primer/template titrations, 1mM ATP was also included. DNA/DNA or 
RNA/DNA primer/template were titrated across 0-1µM. For ATP or ATPγS 
titrations, DNA primer/template was included at 600nM, and nucleotide was 
titrated across 0-1mM. For ATPγS doping experiments the nucleotide 
concentration was held constant at 1mM, and the ratio of ATP/ATPγS ranged 
from 0-100%. For mutant clamp loader doping experiments (T57A), the clamp 
loader concentration was held constant at 7.5nM. T57A and WT were mixed and 
allowed to equilibrate for 24 hours before initiating the reaction with ATP. 
Absorbance was measured in a 96-well format with a Perkin–Elmer Victor3 1420 
multichannel counter using an excitation filter centered at 355 nm, with a 
bandpass of 40 nm. In this assay, every NADH oxidized to NAD+ corresponds to 
one ATP hydrolyzed. Initial slopes were linearly fit to obtain rates, which were 
plotted as a function of primer/template concentration. Data comparing the rate of 
ATP hydrolysis to substrate concentration (either primer/template for DNA 
binding assays or ATP or ATPγS for ATP binding assay) were fit using the 
equation: v = Vmax * [S] /(Khalf-maximal + [S]), where Vmax is the maximum rate and 
Khalf-maximal is the substrate concentration that yields half-maximal activity. For 
examining cooperatively, data were fit to a Hill equation: v = Vmax * [S]n /(Khalf-
maximal
n + [S]n), where n is the Hill coefficient. Data from ATPγS doping assay 
were fit to an equation describing a random, sequential, or concerted model, 
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below. The models assumes all binding sites are occupied and three ATP 
hydrolysis events. In these models, [A] and [G] refer to concentrations of ATP 
and ATPγS, respectively. The models also take into consideration the respective 
affinities for ATP and ATPγS binding to the clamp loader as Kd,ATP and Kd,ATPγS, 
respectively. For a random model, the order of ATP hydrolysis events is not 
taken into account. For a sequential model, activity will be reduced depending on 
the subunit where ATPγS is bound; when ATPγS is bound in an upstream 
subunit, all subsequent ATP hydrolysis will be blocked. For a concerted model, 
ATP hydrolysis will occur in an “all or none” mechanism; the only ATPase activity 
occurs when ATP occupies all sites.  
 
 
 
Random: 
 
!! ∗ !!"# ( 3 ! !!!,!"#! ) + ( 2 ! ![!]!!,!"#! !!,!"#$% ∗ 3) + ( [!] ! !!!,!"#!!,!"#$%! ∗ 3)1 + [!]!!!,!"#! + [!]!!!,!"#$%! + [!]![!]!!,!"#! !!,!"#$% ∗ 3 + [!][!]!!!,!"#!!,!"#$%! ∗ 3 + ! [!]!!,!"#!!,!"#$% ∗ 6 + [!]!!!,!"#$%! ∗ 3 + [!]!!!,!"#! ∗ 3 + [!]!!,!"#$% ∗ 3 + [!]!!,!"# ∗ 3  
 
Sequential: 
 
!! ∗ !!"# ( 3 ! !!!,!"#! ) + ( 2 ! ![!]!!,!"#! !!,!"#$%) + ( [!]![!]!!,!"#! !!,!"#$%) + ( [!] ! !!!,!"#!!,!"#$%! )1 + [!]!!!,!"#! + [!]!!!,!"#$%! + [!]![!]!!,!"#! !!,!"#$% ∗ 3 + [!][!]!!!,!"#!!,!"#$%! ∗ 3 + ! [!]!!,!"#!!,!"#$% ∗ 6 + [!]!!!,!"#$%! ∗ 3 + [!]!!!,!"#! ∗ 3 + [!]!!,!"#$% ∗ 3 + [!]!!,!"# ∗ 3  
 
Concerted: 
 
!! ∗ !!"# ( 3 ! !!! !"#! )1 + [!]!!!,!"#! + [!]!!!,!"#$%! + [!]![!]!!,!"#! !!,!"#$% ∗ 3 + [!][!]!!!,!"#!!,!"#$%! ∗ 3 + ! [!]!!,!"#!!,!"#$% ∗ 6 + [!]!!!,!"#$%! ∗ 3 + [!]!!!,!"#! ∗ 3 + [!]!!,!"#$% ∗ 3 + [!]!!,!"# ∗ 3  
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Results 
DNA vs. RNA primer/template binding 
A critical step in the clamp loader reaction is binding of the clamp/clamp 
loader to primer/template DNA. To date, all crystal structures of primer/templates 
bound to the clamp loader were composed only of DNA duplexes, despite the 
fact that most systems use a RNA primer (103, 116). Therefore, we hypothesized 
RNA/DNA primer/template-junctions would act as better substrates for the clamp 
loader than DNA/DNA primer/template-junctions. We sought to investigate 
biochemical and structural differences between DNA vs. RNA primer strands. 
Binding affinities of DNA versus RNA substrates would quantify any 
preference of the clamp loader possesses for either substrate. We used an 
anisotropy-binding assay in order to determine the dissociation constant for DNA 
primer template to WT T4 clamp loader, as has been used previously (47, 103, 
116, 124). T4 clamp loader was titrated into TAMRA-labeled primer/template 
DNA incubated with the T4 sliding clamp and non-hydrolyzable ATP analog, 
ADPBeF3. Anistropy increased as clamp loader was titrated in (Figure 4.7). 
Surprisingly, the data show a steep dependence of anistropy on clamp loader 
concentration and the data showed a poor fit to an equation describing a 
bimolecular reaction. We therefore fit the data to a tight-binding equation and the 
measured KD was approximately 56 nM ± 23nM. Because the concentration of 
DNA in this assay was higher than the KD  (100nM), we were indeed under tight 
binding conditions. We therefore switched to an enzyme-coupled ATPase assay 
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where we could decrease concentrations of components in the assay and 
monitor binding in a reasonable amount of time (Figure 4.8) (238).  
 Using the enzyme-coupled ATPase assay, we determined apparent 
dissociation constants for both DNA/DNA and RNA/DNA primer/templates bound 
to WT T4 clamp loader in the presence of the clamp and ATP (Figure 4.9). 
DNA/DNA bound with a KD,app = 25 ± 2 nM and RNA/DNA bound with a KD,app = 
10 ± 2 nM. In support of our hypothesis, the RNA/DNA primer/template hybrid 
bound with ~2-fold higher affinity than a DNA primer/template. The RNA primer 
also appears to reduce the maximal fraction bound compared to DNA. One 
possible explanation for this is the quantification for nucleic acid concentration 
was inaccurate and the RNA/DNA primer/template was less concentrated than 
DNA/DNA primer/template.  
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Does ATP hydrolysis occur sequentially? 
 Primer/template binding triggers ATP hydrolysis in the pentameric clamp 
loader spiral (118, 126, 127). Because a recent crystal structure of the T4 clamp 
loader:clamp bound to primer/template DNA and the non-hydrolyzable analog 
ADPBeF3 showed the B-subunit in a post-hydrolysis state (103), we 
hypothesized that ATP hydrolysis initiates in the B subunit, and proceeds 
sequentially around the ring from B-subunit to C-subunit to D-subunit. This 
mechanism is in contrast to a random order, where subunits hydrolyze ATP 
independently of one another, or a concerted mechanism in which all active sites 
hydrolyze ATP simultaneously.  
 We used the weakly hydrolyzable ATPγS analog in a doping assay to 
distinguish between different mechanisms for ATP hydrolysis activity. As 
increasing amounts of ATPγS bind to the available sites in the clamp loader, 
there is a higher probability of decreased ATPase activity. If ATP hydrolysis is 
random, ATPase activity should decrease linearly with respect to ATPγS 
concentration. However, if ATPase activity is sequential, ATPase activity will 
have a steeper dependence on the ratio of ATP/ATPγS. Finally, if ATPase 
activity is concerted, ATPase activity will have a sharp dependence on the ratio 
of ATP/ATPγS, as the only ATP hydrolysis events will occur simultaneously if 
ATP is bound to all active sites. To quantify these differences, we generated 
mathematical models to distinguish between these mechanisms (Figure 4.10a). 
These models assumed three ATP hydrolysis events, and also assume all 
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binding sites are occupied by ATP or ATPγS. These models require the Km for 
nucleotide binding to the clamp loader, which I separately measured to be 79 ± 7 
µM and 48 ± 12 µM for ATP and ATPγS, respectively (Figure 2.11). I again used 
the enzyme-coupled ATPase assay, modified as a doping experiment wherein 
the total nucleotide concentration is constant, but the ratio of ATP to ATPγS is 
varied.  The results of this experiment show a decidedly non-linear decrease in 
ATPase activity (Figure 2.10b), but the data I collected results in an even more 
pronounce curvature than all three of my models. The curvature of my data rules 
out a random model, leaving a sequential or concerted ATP hydrolysis 
mechanism as possibilities. The structure of the T4 clamp loader showing the B-
subunit in a post-hydrolysis state argues against a concerted model, suggesting 
a sequential ATP hydrolysis mechanism. I will further discuss the discrepancies 
between my data and the derived models below.  
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Figure 4.10: ATP hydrolysis likely occurs sequentially. 
a) Expressions describing a random (top) sequential (middle), or concerted 
(bottom) mechanism for ATP hydrolysis. Each expression assumes 3 occupied 
binding sites for T4 clamp loader. For a random model, the order of hydrolysis 
events is not taken into account. For a sequential model, activity is reduced 
depending on the subunit where ATPγS is bound. For a concerted model, the 
only ATPase activity will occur when ATP is bound in all three sites, and will 
simultaneously hydrolyze. [A] and [G] refer to the concentrations of ATP and 
ATPγS, respectively.  
b) Clamp loader ATPase activity in the presence of increasing amounts of 
ATPγS/ATP (blue circles) shows a non-linear rate dependence on ATPγS. The 
models for ATP hydrolysis are shown in (red), sequential (green), or concerted 
(orange). A random model shows activity decreases linearly; sequential or 
concerted models show activity decreases non-linearly. Error bars show standard 
error of the mean, n=3. 
  


 144 
would disrupt ATP hydrolysis. In a modified doping assay, I held the overall 
clamp loader concentration constant, but increased the ratio of T57A/WT titrated 
into the assay. To allow for sufficient subunit exchange, especially given the low 
concentration, aliquots were mixed 24 hours prior to running the experiment. We 
expected to see a decrease in ATPase activity as we increased the ratio of 
T57A/WT because there is a higher probability of subunits deficient in ATP 
hydrolysis in the complex as we increase the mutant. Indeed, increasing the ratio 
of T57A/WT disrupts ATP hydrolysis. The steep dependence on the T57A/WT 
ratio also supports a sequential mechanism (Figure 4.12b). However, the T57A 
variant does not bind DNA with a measurable affinity (Figure 4.12c). Because 
primer/template binding is required for efficient ATP hydrolysis, the steep 
dependence on the T57A/WT ratio could be due to the hybrid clamp loaders 
inability to bind DNA effectively. Therefore, we cannot reasonably conclude a 
sequential hydrolysis mechanism using this mutant.  
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Discussion 
 The clamp loader is essential for loading the sliding clamp onto 
primer/template junctions in an ATP-dependent manner. The field has satisfied 
our understanding for how the clamp loader engages with a primer composed of 
DNA (47, 103, 116), we lack the same insight for how a clamp loader engages 
with its preferred substrate, a RNA/DNA primer/template. Previous studies have 
studied how ATP hydrolysis occurs in the clamp loader (103), but there is a gap 
in knowledge for how ATP hydrolysis relates to the mechanism of clamp loading 
and clamp loader ejection.  
 
An RNA primer binds the clamp loader tighter than a DNA primer 
 We aimed to structurally and biochemically characterize how an RNA 
primer interacts with the clamp loader. We first examined primer/template binding 
using an anisotropy assay that had been previously used (103, 124). The 
anisotropy data showed a steep dependence on the clamp loader concentration, 
indicating we were under tight binding conditions (Figure 4.7). Indeed, when fit to 
a tight-binding equation, the KD was ~56 nM, lower than the concentration of 
DNA/DNA (100nM) in the assay. To avoid tight binding conditions, I could have 
used a lowered concentration of DNA; however, the binding reaction was very 
slow (each independent replicate took one day), so decreasing the DNA 
concentration would only aggravate this problem. Switching to a an enzyme-
coupled ATPase assay, where we could more easily assay both primer/template 
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binding, as well as investigate ATPase activity further facilitated determining if an 
RNA primer was in fact a better substrate.   
 The data using ATPase activity as readout indicate that a RNA primer 
binds to the clamp loader with a 2-fold tighter affinity than a DNA primer (Figure 
4.9). The higher affinity supports our hypothesis that a RNA primer would interact 
more favorably than a DNA primer.  We believe the increase in affinity occurs 
because a RNA/DNA primer/template is already A-form in solution, and would 
not have to undergo conformational change like a B-form DNA primer. However, 
it has been estimated that there is a Gibbs free energy difference of ~2.8 
kcal/mol for the conversion of B-form DNA to A-form for a DNA hexamer (240). 
This difference in free energy supports our hypothesis that an RNA/DNA would 
bind with tighter affinity, this energy difference actually corresponds to a ~113-
fold difference in KD at room temperature. This difference is much higher than my 
data only showing a 2-fold difference in KD, making a crystal structure showing 
the form of RNA/DNA bound to the clamp loader of great interest.  We also 
learned that the RNA/DNA primer/template also reduces the maximal fraction 
bound, which raised several questions. An important technical aspect to consider 
is perhaps quantification of our RNA/DNA concentration was actually less than 
observed, which would explain the reduction in bound primer/template.  If this is 
not the case, several questions still remain—is the RNA primer reducing clamp 
loader enzymatic activity? Does the RNA primer bind more slowly than DNA? Is 
primer/template release slower with an RNA primer? A crystal structure of clamp 
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loader bound to an RNA/DNA hybrid would reveal how the RNA primer activates 
ATP hydrolysis.  
 An RNA/DNA, A-form crystal structure would potentially reveal a network 
of contacts that better represents the primary clamp loader interactions. The 
existing T4 clamp loader structure is in a pseudo-A form (103) and therefore may 
not possess interactions that occur with a true A-form duplex. Therefore a 
structure with an RNA primer may possess slightly different template strand 
interactions with the clamp loader, consequently altering contact with the switch 
residue, which would explain the possible decrease in enzymatic activity seen by 
the ATPase assay. Additionally, a structure would help explain energetic 
differences from potential conversions of B-form to A-form nucleic acid 
structures. If there is a 2.8 kcal/mol difference in free energy between B- and A-
form, we would expect RNA/DNA binding to be much tighter than we observed. 
Perhaps a RNA/DNA primer/template undergoes an energetically unfavorable 
conformational change to pseudo-A form, which may account for the differences 
in binding. However, my crystallization attempts were unsuccessful using both 
the T4 and E.coli clamp loaders, so this remains an open question.  
From examining the T4 co-crystal structure, we have identified a residue 
(gp44-S112) that may directly interact with an RNA primer more favorably than 
DNA primer. To test this hypothesis, we have prepared two variant clamp loaders 
S112A and S112K that we predict to perturb primer/template junction binding. 
S112A is predicted to remove the RNA-specific interaction; therefore, the affinity 
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for an RNA/DNA hybrid would be predicted to be reduced, but the affinity for a 
DNA/DNA hybrid would be unchanged. S112K is predicted to disrupt the 
interaction with an RNA/DNA hybrid, but provide a new interaction with a 
DNA/DNA hybrid. Thus, these two mutations make testable predictions with 
regards to the mechanism of primer/template junction binding. We have 
expressed S112A and S112K, but not yet tested for any differences for binding to 
a DNA or RNA/DNA primer/template. These experiments will be a focus of future 
studies.  
 
ATP hydrolysis likely occurs sequentially 
  I sought to understand how ATP hydrolysis occurs around the clamp 
loader spiral. Based on a co-crystal structure of the T4 clamp loader showing the 
B-subunit in a post-hydrolysis state, we hypothesized ATP hydrolysis begins at 
the B-subunit and propagates around the spiral. Our preliminary data suggests 
that ATP hydrolysis in clamp loader occurs sequentially and not randomly. Using 
an ATPγS doping experiment, we observe a steep dependence of ATPase 
activity on ATP/ATPgS ratio. This data rules out a random ATP hydrolysis model. 
The measurements are in accord with the sequential model or concerted models, 
albeit with a more pronounced curvature. However, an “all or none” concerted 
model is not supported by previous studies in the clamp loader field; a study from 
T4 clamp loader using kinetic measurements showed two molecules of ATP 
hydrolyze sequentially, followed by additional ATP hydrolysis events (241). This 
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data argues against ATP hydrolysis occurring at all sites simultaneously. 
Additionally, a crystal structure of the T4 clamp loader that shows only one 
subunit has hydrolyzed ATP does not support a concerted mechanism (103). In a 
concerted mechanism, all molecules of ATP will hydrolyze simultaneously.  We 
therefore rule out concerted as a probable ATP hydrolysis mechanism.  
We derived the sequential model assuming three hydrolysis events. 
Previous studies have also reported that three hydrolysis events are sufficient for 
clamp loading activity (113). Surprisingly, a model describing four hydrolysis 
events would fit to this data better. Even though all four of the gp44 subunits in 
the T4 clamp loader can bind ATP, it is unlikely that all four can hydrolyze ATP 
due to the lack of an “arginine finger” contributing to the active site in the E-
subunit. The arginine finger is a conserved basic residue that functions in trans to 
activate ATP hydrolysis in a neighboring subunit. The crystal structure of the T4 
clamp loader does not reveal any arginines or lysines that are in position to 
coordinate catalysis in the E subunit (103). However, there are two basic 
residues in the A’ domain, K129 and R130, that are somewhat proximal to the 
bound ADP and Mg2+ in the E-subunit active site. These residues are too far 
(>18Å) from the gamma phosphate of ATP for any direct interaction, but it is 
possible that the A’ domain can undergo a large ~35° rotation to position either of 
these residues for catalysis. If so, either K129 or R130 may act as an arginine 
finger, which would support a four-hydrolysis event model. This could easily be 
investigated further via mutation and testing using the ATPase assay; if one of 
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these residues was acting as an arginine finger, ATP hydrolysis rate would 
decrease by ¼ relative to the WT.   
 There are several alternative explanations for the steepness of the data 
due to technical aspects of the ATPγS doping experiment. We show that the 
clamp loader is still active in the presence of ATPγS, indicating that it hydrolyzes 
ATPγS, albeit slowly. Once converted to ADP, pyruvate kinase will convert ADP 
to ATP, which will perturb the ATP/ATPγS ratio. Moreover, we determined our 
stock of ATPγS contains contaminating ADP, which will be converted to ATP by 
pyruvate kinase in the coupled enzyme mix. We monitored the effect of 
nucleotide on pyruvate kinase in the assay in the absence of clamp loader 
(Figure 4.13). The signal from ATPγS alone suggests contaminating ADP in our 
stock. When ATPγS is mixed with ADP, the results are additive compared to 
ADP or ATPγS alone. We estimate that there is a ~25% contamination of ADP in 
the ATPγS stock, which make the interpretation of our ATPγS doping assay 
nearly impossible. Because of the success from data I discussed in Chapter II, I 
abandoned these studies to focus on the sliding clamp variant. 
 A previous study on the T4 clamp loader suggested ATP hydrolysis is 
cooperative in the presence of primer/template DNA, which supports a sequential 
hydrolysis model; if hydrolysis occurs at one subunit, it could promote hydrolysis 
at an adjacent site (242). Conversely, our doping experiments do not appear to 
be cooperative; when ATPγS binding data was fit to a Hill equation, the Hill 
coefficient was 0.98 ± 0.28 µM. Likewise, when ATP binding data was fit to a Hill 
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Because of the technical limitations of the ATPγS doping assay, we 
designed an experiment with potentially more discriminating power. Based on 
previously published mutants (116, 239), we mutated a conserved threonine 
residue within the active site, gp44-T57A, to disrupt hydrolysis. We modified the 
doping experiment to increase the ratio of T57A/WT and observed a non-linear 
decrease in ATPase activity. This data would support a sequential ATP 
hydrolysis mechanism, but unfortunately, this mutant does not bind DNA. The 
abolished binding was surprising, given the equivalent mutation in the E. coli 
clamp loader is fully competent to bind DNA (116).  Regardless, we cannot 
conclude the results from this doping assay are due to a sequential ATP 
hydrolysis mechanism.  
 Several other studies have also proposed a sequential ATP hydrolysis 
mechanism in clamp loaders (243, 244). However these studies suffer from 
similar difficulties, particularly disruption of DNA binding, similar to my results 
with the T57A variant. In one study using the E. coli clamp loader, the arginine 
finger in the γ (R169) and δ’ (R158) subunits, equivalent to the B/C/D and E 
subunits respectively, were mutated to alanine. While γ-R169A is inactive, δ’-
R158A retains some ATPase activity, due to its location in the complex 
(equivalent to the E-position). The authors argued that because the mutated 
arginine finger, δ’-R158A, would be involved in the final hydrolysis event of the 
sequence, some activity remained from ATP hydrolysis occurring in the subunits 
at the bottom of the spiral. However, as previously stated, these mutants do not 
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bind DNA, bringing into question the validity of the interpretation. A second study 
uses the eukaryotic clamp loader, the RFC complex, and mutated the Walker-A 
lysine residue to alanine. While their results are also consistent with a sequential 
hydrolysis mechanism, these mutants also fail to bind DNA (244). Additionally, 
this study did not account for ATPγS being weakly hydrolysable.  
 The eukaryotic clamp loader, RFC, is a heteropentamer, so designing 
mutations to target specific subunits is more easily facilitated in this system. 
Thus, if we could identify a mutation that disrupts ATP hydrolysis but not DNA 
binding, then we could determine an order for ATP hydrolysis by reconstituting 
RFC clamp loader variants with individual subunits inactivated for ATP 
hydrolysis. We would predict that inactivation of the B subunit would have the 
greatest reduction on ATPase activity. Conversely, inactivation of downstream 
subunits would have less of an effect on ATPase activity. A strong candidate for 
such a variant is the conserved sensor-1 motif threonine mutated to alanine in 
RFC1-T360A, RFC2-T72A, RFC3-T60A, and RFC4-T56A. These mutations in 
this system may therefore be able to definitively address the order of ATP 
hydrolysis. 
 To conclude, the clamp loader reaction contains several critical steps, and 
our investigation supports potential mechanisms for two of those steps; first, how 
primer/templates bind to the clamp:clamp loader complex, and second, if ATP 
hydrolysis occurs sequentially. My data here show RNA/DNA primer/template 
binds with 2-fold tighter affinity, but raises several questions about how the 
 155 
primer strand interacts with the clamp loader. I demonstrate that ATP hydrolysis 
is likely sequential, but more work is required to tease apart the order of ATP 
hydrolysis around the clamp loader spiral. Future work using the structural and 
biochemical approaches described herein will help reveal these mechanisms, 
which would further elucidate general mechanisms of AAA+ machines. 
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CHAPTER V 
 
Discussion   
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Discussion 
My overall goals for this thesis were to structurally and biochemically 
characterize regulatory roles for two protein complexes essential for DNA 
replication: the sliding clamp and the sliding clamp loader. The clamp surrounds 
DNA and acts as a scaffold for interacting partners to carry out their function on 
DNA. As such, the clamp interacts with a vast network of proteins, orchestrating 
many cellular processes including DNA replication and repair, cell cycle 
regulation, chromatin remodeling, and epigenetic inheritance (57). The ring-
shaped clamp does not interact with DNA on its own accord; it must be actively 
placed onto primed DNA by the sliding clamp loader in an ATP-dependent 
reaction (100). In the presence of ATP, the sliding clamp loader binds and opens 
a closed clamp. The clamp loader couples primer/template binding, and 
subsequent ATP hydrolysis to clamp closure around DNA (100). Although much 
is understood about the clamp and clamp loading process, I sought to address 
gaps in the current understanding. I summarize my findings for the sliding clamp 
and sliding clamp loader, and discuss open questions and future directions, 
below.  
 
Summary: The sliding clamp 
In Chapter II, I investigated the structural and biochemical consequences 
of a recently identified and novel disease-causing mutant in the human sliding 
clamp, PCNA (proliferating cell nuclear antigen). This mutant, PCNAS228I, had 
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been previously hypothesized to cause defects in DNA repair (35, 185), with 
clinical symptoms that mimic other related DNA repair disorders. However, the 
mechanism underlying the disease was not understood. Of particular interest 
was that this mutation, in a protein as critical as PCNA, was not lethal.  
My structural studies reveal that the disease mutation disrupts a 
promiscuous binding site called the IDCL (interdomain connecting linker) in 
PCNA (Figures 2.2, 2.6). Because PCNA interacts with >100 partner proteins at 
the IDCL, I investigated whether the disrupted binding site was still compatible for 
known PCNA interacting partner (PIP) binding. Structural and biochemical data 
revealed the IDCL of the S228I variant is pliable and accommodates PIP ligands 
idiosyncratically (Figures 2.7, 2.9, 2.11) (63).  
Of the three PIPs we tested for binding, FEN1 and RNaseH2B showed 
substantial loss of binding affinity to the mutant variant. This data supports the 
claim from a previous study that the underlying cause of the disease is a defect 
in DNA repair (35, 185), but the previous authors specifically described a defect 
in nucleotide excision repair (NER), and neither FEN1 nor RNaseH2B function in 
NER. The RNaseH2B data also suggests a defect in ribonucleotide excision 
repair (RER) could contribute to the disease. While our major findings in Chapter 
II were specific to the mutant PCNA, our comparison with WT PCNA revealed 
important insights into normal PCNA function that could have implications for 
PCNA dynamics, regulation, and function, which I discuss further below. 
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In order to identify the source of the disease phenotype, I developed an in 
vivo model system to further understand how the PCNA variant affects cellular 
pathways. In Chapter III, I describe a fission-yeast model system to study the 
cellular effects of the S228I mutant variant. Using a strain harboring pcn1-S288I 
as the sole copy of pcn1, I conducted growth assays after treating cells with DNA 
damaging agents. I am limited in making strong conclusions about potential 
defects in DNA repair pathways because the DNA damaging agents only 
revealed a weak phenotype (Figures 3.5-3.8). We were initially surprised that 
there was no response to UV light, given patients are highly sensitive to sunlight; 
however, there is an additional DNA UV repair pathway in fission yeast that likely 
protects pcn1-S228I from significant UV damage (217, 218).  
 
Open Questions: The sliding clamp 
A major unanswered question in the PCNA field is how binding of PIPs are 
regulated in a spatiotemporal manner. Because PCNAS228I disrupts a major 
binding site, we sought to use this mutant as a tool to probe what drives binding 
specificity. We obtained new insights into normal PCNA function from studying 
this mutant, including that the IDCL binding site may be more flexible than 
previously indicated from static crystal structures. Additionally, during our 
analysis of clamp structures, particularly when analyzing the crystal structure of 
WT human PCNA bound to the PIP-box peptide from polymerase κ, we observed 
that PCNA contains an uncharacterized disulfide bond (60). We believe this 
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disulfide bond may regulate binding specificity. I will discuss implications of these 
findings, and how we can further investigate them below. 
 
What are the implications of a flexible binding site? 
The data from Chapter II reveals that the IDCL is more flexible than 
current structural models suggest, likely because alternate conformations are 
often masked in static crystal structures. Are the novel conformations we 
observed with PCNAS228I structures accessible for the WT protein? Additionally, 
what are the physical constraints to which conformations the IDCL can adopt? In 
the disease-causing mutant variant, the IDCL mobility is actually dampened, as 
evidenced by a reduction in normalized B-factors relative to other PCNA 
structures (63, 64). These results suggest flexibility is important for cellular 
fitness.  Knowing that PCNA is a promiscuous binding partner, we hypothesize 
that dynamics within the IDCL regulate partner binding, and that a flexible IDCL 
region is important for PCNA to maintain interactions with all of its binding 
partners. We can use several strategies to test these hypotheses.  
 Recently developed x-ray crystallography techniques can help probe 
differences in IDCL conformations. Low-temperature (~100K) data acquisition 
strategies typically identify only the most populated state (245-247). As such, 
most conformational heterogeneity is lost. Alternatively, data acquisition at room 
temperature can identify multiple higher-energy states (246). For PCNA, these 
higher-energy states might reveal dynamics within the IDCL that regulate binding 
 161 
interactions. Room temperature data collection does cause higher radiation 
damage, but recent advances in data acquisition (namely, larger x-ray dosage 
combined with faster data collection) have been shown to reduce radiation 
damage (247). Additionally, advances in ensemble x-ray crystallographic 
refinement can help identify alternative conformations for data collected at low 
temperature or room temperature: qFit software automates building and 
refinement of alternative conformations within models (248, 249), while Ringer 
analysis reveals additional conformational diversity in electron density maps 
(below 1σ) that would otherwise be overlooked as noise with traditional model 
building and refinement (246, 250). However, in order to take advantage of these 
techniques, we must improve our crystals of WT and mutant PCNA to yield 
higher resolution diffraction data (<2Å). We have some preliminary data (see 
Appendix A1) on our efforts to improve crystal quality. I have identified multiple 
crystal forms grown in various conditions, which we can readily screen at our 
home source. This maximizes the potential to improve resolution to the range 
required to study the IDCL dynamics. This will be the focus of future studies.  
 What are the cellular effects of changes in the IDCL region? Based on 
data in Chapter II, we know that the mutant variant disrupts a promiscuous 
binding site in PCNA, and that the binding site is especially flexible. Surprisingly, 
the IDCL in the disease-causing variant is actually less mobile than the WT, 
suggesting that the IDCL flexibility is important for fitness. If mutations in the 
IDCL disrupt fitness in vivo, I would expect these mutations would reduce 
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flexibility within the IDCL. Additionally, decreased fitness might also identify 
particularly important residues within the IDCL that are critical for PIP binding. 
We can measure fitness resulting from changes within the IDCL using a 
systematic approach called EMPIRIC (Exceedingly Meticulous and Parallel 
Investigation of Randomized Individual Codons) (251-253). EMPIRIC would allow 
us to investigate all possible amino acid substitutions in the IDCL region and their 
effects on growth rate in yeast. Ideally, we could identify regions within the 
binding site that are critical for dynamics, as well as partner interactions. This 
would comprehensively establish how PCNA interacts with so many proteins in a 
regulated manner.  
In Chapter III, I describe the generation of a valuable tool for further 
investigation of any PCNA-mediated pathways disrupted by pcn1-S228I. Future 
studies could selectively perturb particular DNA repair pathways to determine 
which are affected by the S228I variant. As discussed in Chapter III, we could 
target RER to investigate if the loss of RNaseH2B binding to the PCNA variant 
causes an RER defect. Future studies using this strain could take advantage of 
high-throughput techniques like synthetic genetic arrays (SGA). SGA identifies 
synthetic lethality pairs from a query allele (pcn1-S228I) when crossed to an 
ordered array of gene deletion strains, which are then assayed for growth defects 
(254). Because this mutant variant appears to have a specific defect in DNA 
repair, it would be informative to learn how cellular networks, particularly DNA 
repair networks, are connected in the mutant background.  
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Can the redox state of PCNA regulate binding specify?  
 During our initial analysis of the PCNAS228I structure, we identified a pair of 
cysteines, Cys135 and Cys162, which are proximal to the site of the mutation, 
Ser228. The thiol groups of the cysteines are close (~3.5 Å) to one another, with 
geometry favorable for adopting a disulfide bond. These cysteines are also near 
Lys164, which serves as a site for post-translational modification by mono- and 
poly-ubiquitnaylation and SUMOylation (56). Upon reviewing the available crystal 
structures of WT PCNA, we discovered that the co-crystal structure of PCNA 
bound to the PIP box peptide from Pol κ was modeled with these cysteines in a 
disulfide bond (Figure 5.1) (60). Several proteins involved in DNA repair 
pathways have been previously shown to act as redox sensors, including AP 
endonuclease 1 and XRCC1 (255, 256). These proteins have been shown to 
directly interact with PCNA (189, 191). Additionally, the oxidation state of these 
proteins has also been shown to regulate binding partners. Intriguingly, Ubc9, 
which is the enzyme that SUMOylates PCNA at Lys164 (87), was recently shown 
to be controlled by redox conditions in the cell (257). These studies suggest that 
this disulfide motif in PCNA may control the binding of PIPs. Additionally, 
because XRCC1 lacks a PIP-box motif (191), this interaction may be specifically 
regulated by the oxidation state of PCNA. To our knowledge, there are no reports 
characterizing PCNA as a redox sensor. Therefore, I hypothesize the oxidation 
state of PCNA modulates binding specificity to various PIPs.  
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This hypothesis could be investigated in multiple ways. To identify if this 
disulfide bond forms under physiological conditions, we can pulldown PCNA from 
established cell lines (HeLa cells, for example), and compare protein mobility on 
reducing or non-reducing SDS-PAGE gels. As another approach we can purify 
WT, PCNAC135A, PCNAC162A, or the double mutant PCNAC135A/C162A in either the 
absence or presence of reducing agent. I have already established a protocol for 
PCNA purification in the absence of reducing agent. With purified protein in the 
oxidized or reduced state, we can test for differences in binding to PIP-box 
peptides using my established protocols for PCNA isothermal titration 
calorimetry. Given oxidative species generate responses from DNA repair 
pathways (258), I expect that PIPs involved in DNA repair would bind to oxidized 
PCNA with tighter affinity.  
If we have success with identifying alternate conformations of the IDCL 
using multi-conformation ensemble refinement techniques, it would also be of 
interest to investigate if a disulfide bond in PCNA alters IDCL conformations in 
conjunction with altering binding affinity for PIPs. Advances in data collection 
would also help circumvent issues for x-ray radiation damage that can destroy 
disulfide bonds (259). 
 Given the vast number of clamp binding partners, I would expect there 
would be multiple ways to modulate these interactions. If we can further 
understand how binding is regulated in the WT protein, we can easily apply 
similar approaches to determine why binding is abrogated for the disease-
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causing variant PCNAS228I. These findings would provide insight for not only the 
underlying mechanism for the disease and identifying possible therapeutic 
approaches, but also as a means of characterizing the hierarchy of how PCNA 
interactions occur. Finally, reagents generated here will be useful for teasing 
apart how these actions are coordinated spatially and temporally in the cell.   
 
Summary: The sliding clamp loader 
In Chapter IV, I investigated two critical steps in the clamp loader reaction: 
primer/template binding and ATP hydrolysis. Most previous biochemical and all 
structural studies investigating primer/template binding to the clamp loader used 
a DNA primer, when, in fact, most clamp loaders primarily use an RNA primer 
(22). I sought to understand how the T4 bacteriophage clamp loader engages 
with an RNA/DNA primer/template. A co-crystal structure of T4 clamp 
loader:clamp:primer/template duplex DNA showed that DNA was A-form, instead 
of the more common B-form (29, 103). We hypothesized a RNA primer would 
interact more favorably than a DNA primer because RNA/DNA duplexes are 
already A-form. Binding studies show that an RNA primer does bind with 2-fold 
tighter affinity than a DNA primer, but may reduce the maximal fraction bound 
(Figure 4.9). Crystallization of the full complex proved difficult and I was 
unsuccessful in obtaining a structure that would help explain these differences.  
In addition to primer/template binding, I sought to understand the 
sequence of ATP hydrolysis around clamp loader spiral. Based on a co-crystal 
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structure showing the B-subunit in the clamp loader in a post-hydrolysis state 
(103), we hypothesized that ATP hydrolyzes sequentially around the spiral, 
beginning from the B-subunit. I generated mathematical models to distinguish 
between random, sequential, and concerted hydrolysis mechanisms (Figure 
4.10a). Data from an ATPγS doping experiment ruled out a random ATP 
hydrolysis mechanism (Figure 4.10b), and previous studies have ruled out a 
concerted mechanism (103, 241). Although the data suggests a sequential 
mechanism, the data does not perfectly fit our model, which is likely due to 
technical aspects of the assay, but could also be due to faulty assumptions in the 
model, which I will discuss below. I tried to corroborate these results through an 
alternate mutant doping strategy, but the T57A mutant does not bind DNA 
(Figure 4.12c). Therefore we could not conclude a sequential ATP hydrolysis 
mechanism using this mutant due to the coupling between primer/template 
binding and ATP hydrolysis (118, 126, 127). 
 
Open questions: The sliding clamp loader 
 The limited data I collected in Chapter IV does not fully address the two 
goals I hoped to accomplish. For RNA/DNA primer/template binding, we are 
limited in making conclusions for how RNA interacts with the clamp loader 
without a crystal structure. By no means have we exhausted options for 
crystallography; my attempts to crystallize the clamp loader bound to RNA/DNA 
primer template were not comprehensive. My approach, including 
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primer/template design, were modeled after the T4 clamp loader structure (103). 
Future experiments should vary primer/template lengths, which may aid 
crystallization. My efforts to crystallize clamp loader components from E. coli 
were brief and focused exclusively on conditions established for a DNA/DNA 
primer/template (116). Future studies could expand upon the sparse screening 
conditions or utilize an orthologous clamp loader. Structural studies would help 
address how an RNA primer interacts with the clamp loader, but they also could 
reveal a yet-unknown intermediate in the clamp loader reaction: what a clamp 
loader bound to an open clamp looks like in the absence of DNA.  
Optimizing the biochemical approach may provide insight into clamp 
loader RNA versus DNA primer recognition. I abandoned the anisotropy assay to 
measure binding primarily due to the tight binding of duplexes relative to the 
concentrations used in the assay, but the binding reaction was also very slow. 
Future work could explore utilizing lower DNA concentrations, despite the risk of 
a reduced signal and slower reaction times. Exploring conjugation of different 
fluorophores to the substrate DNA may provide a better signal to measure 
binding at lower DNA concentration. Optimization of the anisotropy assay and 
further utilization of the enzyme-coupled assay provide a dual approach to 
investigating clamp loader mutants. Future experiments could thus identify 
residues critical the RNA/DNA binding as well as discriminate between the 
different duplexes.  
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My studies into sequential versus random ATP hydrolysis can also be 
expanded. My data demonstrate that hydrolysis is likely sequential. However, a 
four-hydrolysis event model is in better agreement with the data relative to a 
three-hydrolysis model, which was puzzling given three subunits, B, C and D, 
hydrolyze ATP and are sufficient for clamp loading; the A-subunit lacks the AAA+ 
fold and does not bind ATP (103, 110, 113). This is due to a conserved feature of 
AAA+ ATPases called the arginine finger (106). The arginine finger reaches 
across subunit interfaces into the active site of a neighboring subunit to stabilize 
the negative charge on the γ-phosphate of ATP and aid catalysis. For example, 
the arginine finger in subunit C reaches into the active site of subunit B. Because 
the clamp loader is a pentamer, with a gap between subunits A and E, there is no 
arginine finger to present to the active site of subunit E. However, from 
examining the T4 clamp loader crystal structure, there are two putative arginine 
fingers located in the A’ domain. As discussed in Chapter IV, these two basic 
residues, K129 or R130, may support a fourth ATP hydrolysis event, adding to 
the proposed three events. Ideally, to discriminate between a three- vs. four-
event hydrolysis mechanism, future studies should probe these possibilities using 
a mutational approach; if either of these basic residues were acting at the 
arginine finger, ATP hydrolysis rate would decrease ¼ relative to the WT. The 
ideal mutant to identify for a doping experiment would disrupt ATP hydrolysis, but 
maintain DNA binding because of the coupling between these two events in the 
clamp loader reaction. A potential candidate for this mutant is the Walker-B 
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catalytic glutamate, E108 in T4 clamp loader gp44 subunits. Several other AAA+ 
ATPases, include the membrane trafficking proteins AAA+ NSF, p97, VPS4, or 
the unfoldase ClpX have shown that mutating the catalytic glutamate to 
glutamine maintains structure and function, but disrupts ATP hydrolysis (260-
262).  
Overall, the work described herein describes regulatory roles for the 
sliding clamp loader. RNA binds to the clamp loader more tightly than DNA, 
which is expected given it is the most common substrate. ATP hydrolysis does 
not occur randomly and is likely sequential, in line with other related ATPases. 
Future structural studies will reveal the mechanisms for these findings in atomic 
detail. 
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Crystallization optimization of WT PCNA and 
PCNAS228I 
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Crystallization optimization of WT PCNA and PCNAS228I 
In Chapter II, we investigated the structural consequences of a disease-
causing variant of PCNA, PCNAS228I (63). A crystal structure of the mutant variant 
shows the mutation induces a large-scale reorganization of the major binding site 
in PCNA, called the IDCL (interdomain connecting loop). Two additional 
PCNAS228I crystal structures bound to peptides from PCNA interacting partners 
(PIPs) each reveal a unique conformation in the IDCL, which suggests this region 
is unusually flexible. To support this observation, we utilized normalized B-factors 
of the IDCL from WT and PCNAS228I structures to investigate flexibility.  The 
PCNAS228I analysis revealed that the highest degree of motion occurs in the IDCL 
region (Figure 2.2d&e). However, when compared with the relative B-factors of 
the WT structure, the WT IDCL is nearly 2-fold higher than the mutant (63, 64). 
Despite having higher relative B-factors, and presumably higher flexibility than 
PCNAS228I, all existing WT PCNA structures exhibit the same IDCL architecture 
(58-62) (63, 64) (Figure 2.4). The mutant IDCL therefore appears more rigid and 
less able to bind some protein partners.  
We hypothesize that the IDCL is exceptionally flexible, but these dynamics 
have been hidden in static crystal structures. Studies of PCNAS228I highlight 
structural diversity within the IDCL binding site, yet the mutant exhibits reduced 
binding to some PIPs (63). Taken together, this suggests that the IDCL 
conformation is especially important for PCNA binding partners. We hypothesize 
that alternative conformations of the IDCL in hPCNA-WT contribute to the 
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specificity of PIP binding. We aim to probe differences in IDCL conformations 
using multi-conformation ensemble refinement techniques (See Chapter V for 
discussion) (249, 263). However, these techniques require high-resolution 
diffraction (<2Å), and must withstand elevated radiation damage that occurs 
during room-temperature data acquisition.  
Here I present crystallography conditions to improve the quality of WT and 
mutant PCNA crystals for multi-conformation ensemble refinement. Previously 
published structures of apo WT PCNA are at 2.3Å resolution (64). The structure I 
solved of apo PCNAS228I is at 2.7Å resolution, but I did not pursue any 
optimization of conditions (i.e., crystal growth conditions, freezing conditions, 
cryogenic buffers, etc.), so it is reasonable to expect improved quality crystals 
after optimization.  
 
Materials and Methods 
 All proteins were crystallized using the hanging-drop vapor diffusion 
method. Drops contained 0.9µL:0.9µL of protein:buffer. To improve crystals for 
PCNAS228I, hand trays were set up to screen around 100mM sodium acetate (pH 
4.0, pH 4.5, pH 4.6) or 100mM Tris (pH 8.5) and between 1.7-2.2M ammonium 
sulfate. Suitable cryogenic buffers contain 25% (v/v) glycerol and elevated 
concentrations of ammonium sulfate. Drops contained 5-20mg/mL protein. 
To improve crystals for WT PCNA, hand trays were set up to screen 
around 100mM sodium acetate (pH 4-5.5), 15-30% PEG 400 (which also serves 
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as a cryoprotectant), and 100mM calcium acetate. Drops contained 5-15mg/mL 
protein. 
 
Results and Discussion  
PCNAS228I crystals form in a range of acidic pH conditions. Diffraction 
quality crystals formed in sodium acetate buffer between pH 4.5 and 4.6 (Figure 
A1.1). Small, jagged plate crystals form at low pH (4.0) (Figure A1.3), and 
crystals do not form at pH 5.0-5.5, or Tris pH 8.5 (not pictured). Within the pH 4-
5.5 range, PCNAS228I forms diamond shaped crystals. 
 
Figure A1.1: PCNAS228I crystal optimization. 
PCNAS228I crystallizes in ammonium sulfate between sodium acetate buffers, 
pH4.5-4.6  
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PCNAS228I crystal nucleation and growth rate can be controlled through 
modulating precipitant concentration. In high precipitant conditions crystals form 
immediately after setting up drops, and most conditions yield crystals within 48 
hours. Decreasing the amount of ammonium sulfate slowed the crystal formation 
rate (crystals formed within one week), and significantly increased crystal size 
likely because of fewer nucleation events. Increasing crystal size could 
potentially provide protection against radiation damage.  
PCNAS228I crystals grown in hanging drops with 5-20mg/mL protein did not 
exhibit a strong correlation between protein concentration and crystal size. In 
order to optimize crystallization and improve diffraction, I recommend optimizing 
drop volume to check for volume dependency, experimenting with various 
protein:buffer ratios, including additive screens, and testing crystal growth at 
varying temperatures. By optimizing these variables, one can grow large single 
crystals that diffract well. Additionally, I also recommend screening different 
cryogenic protectants for freezing PCNAS228I crystals. Cryo-protectants beyond 
25% v/v glycerol were not extensively explored. Ideal freezing is critical for 
achieving high-resolution diffraction. While I have proposed room-temperature 
data collection, optimizing freezing conditions could still prove beneficial; the 
ensemble refinement strategies I discussed in Chapter V can potentially identify 
alternate IDCL conformations from data collected at either low temperature or 
room temperature.  
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WT crystals form between pH 4.5-5.0 at protein concentrations between 5-
15mg/mL. Interestingly, all WT crystals require at least 100mM calcium acetate 
for crystal formation. Calcium acetate concentration also requires optimization. 
We observe multiple crystal forms with WT conditions; we see starbursts at 
higher protein concentrations or increased precipitant concentration, and cubes 
of various sizes at lower precipitant concentration (Figures A1.2, A1.3a). The 
current starburst-form crystals diffract out to ~2.6Å (data was collected at low-
temperature), and are a distinct, novel crystal form from the previously published 
WT structure (Figure A1.3b; courtesy of B. Hilbert) (64). Being novel suggests 
optimization may allow us to achieve diffraction higher than the published WT 
crystal form.  
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Figure A1.2: WT PCNA crystal optimization. 
WT PCNA crystallizes in a range of PEG400 between sodium acetate buffers, 
pH4.0-5.5. 100mM calcium acetate is required for crystallization.  
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Figure A1.3: Summary of PCNA crystal forms and preliminary diffraction 
data. 
a) Two crystal forms are seen with each WT PCNA and PCNAS228I 
b) A starburst crystal (from 25% PEG 400, 1mmM sodium acetate pH4.5, 100mM 
calcium acetate) of WT PCNA diffracts to ~2.6Å (courtesy of B. Hilbert). 
 
 
Plates, S228I
1.7M ammonium sulfate, 
100mM sodium acetate pH 4.0
Starbursts, WT
25% PEG 400
100mM sodium acetate pH 4.5
100mM calcium acetate
Diamonds, S228I
2.1 M ammonium sulfate,
100mM sodium acetate pH 4.5
Large diamonds, S228I
1.5M ammonium sulfate
100mM sodium acetate pH 4.6
Cubes, WT
30% PEG 400
100mM sodium acetate pH 5.0
100mM calcium acetate
Large cubes, WT
28% PEG 400
100mM sodium acetate pH 5.0
100mM calcium acetate
a
b
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Purification of the intact exocyst complex 
 
The following work was done in Dr. Mary Munson’s laboratory, or collaborators’ 
laboratories (noted in text). CMD contributed the following to the attached 
publication (264): 
 
I constructed a set of C-terminally Protein A (PrA) tagged exocyst 
subunits, integrated into the genomic locus of Saccharomyces cerevisiae: SEC3, 
SEC5, SEC6, SEC8, SEC10, SEC15, EXO70, and EXO84. I validated these 
strains by sequencing, western blot, and MALDI-MS. I also constructed a partial 
set of C-terminally GFP-tagged exocyst strains crossed to PrA-tagged exocyst 
subunits, which were validated by western blot. I confirmed the tagged subunits 
in these strains were functional using a serial dilution growth assay. Finally, I 
constructed a set of strains in which one exocyst subunit was PrA-tagged, in the 
background of a temperature-sensitive exocyst allele.  
Using these strains, I optimized an exocyst purification protocol, and 
determined conditions to purify intact complexes from PrA-tagged yeast strains, 
as well as optimize protease cleavage to yield native, untagged complexes. The 
purification strategy was done in collaboration with members of Dr. Michael 
Rout’s laboratory (Rockefeller University). In particular, I optimized lysis 
conditions, as well as purification buffers to ensure complex integrity. In order to 
examine partially destabilized exocyst complexes, I investigated the effects of 
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detergents, chaotropic agents, or high salt on the complex. In order to selectively 
destabilize only one exocyst subunit at a time, I purified complexes from strains 
in which a single exocyst subunit was encoded by a temperature-sensitive allele 
at both permissive and non-permissive temperatures.  
Finally, I initiated negative stain electron microscopy studies on the native, 
purified complex (post-protease cleavage). These studies were done in 
collaboration with members of Dr. Adam Frost’s laboratory (formally at University 
of Utah; currently at University of California, San Francisco). Although I did not 
collect a full dataset of negative stain micrographs, this work produced the first 
look at the intact native complex from S. cerevisiae.  
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A R T I C L E S
Exocytosis is the evolutionarily conserved pathway by which protein 
and lipid cargos are trafficked from intracellular compartments to 
the plasma membrane in membrane-bound vesicles. This pathway 
is essential for cellular growth and division as well as for specialized 
processes such as cell migration, ciliogenesis and autophagy1. 
To maintain the fidelity of the secretory pathway, numerous con-
served protein families regulate every step of the process2. Tethering 
factors, including the multisubunit tethering complexes (MTCs), 
serve as the first long-range, reversible connection between a vesicle 
and its target membrane3,4. However, in many cases, experimental 
evidence demonstrating tethering by these factors is lacking5. Tethers 
have been proposed to provide specificity for vesicle targeting, 
but they may also assume a more active role in regulating SNARE-
mediated membrane fusion3,6–8.
The exocyst complex is the MTC for secretory vesicles at the plasma 
membrane, and it contains eight subunits—Sec3, Sec5, Sec6, Sec8, 
Sec10, Sec15, Exo70 and Exo84—all of which have orthologs in 
eukaryotes including yeasts and humans9–14. Yeast exocyst mutants 
display severe growth and secretion defects and accumulate post-
Golgi secretory vesicles in the cytoplasm15,16. Similarly, null mutants 
in mice and flies exhibit embryonic and larval lethality, respec-
tively17,18. Although previous studies have revealed requirements for 
the exocyst in many critical cellular processes involving polarized 
vesicle trafficking, the structure and mechanisms of tethering by the 
exocyst remain unresolved1.
Similarly to other tethering factors, the exocyst is a peripheral mem-
brane protein complex that interacts with numerous GTPases, SNAREs, 
phospholipids and the vesicle-transport motor myosin V1,3,19,20. 
The exocyst has been proposed to interact with vesicles through 
Sec15 binding to the Rab GTPase Sec4 and myosin V, as well as 
Sec6 binding to the v-SNARE Snc16,19,21. On the target-membrane 
side, both Sec3 and Exo70 interact with Rho GTPases and phos-
phatidylinositol 4,5-bisphosphate22–26, and Sec6 may interact with 
an as-yet-unidentified ‘anchor’ factor at the plasma membrane27. 
It is through this myriad of connections that the exocyst has been 
predicted to selectively capture secretory vesicles and tether them to 
the plasma membrane. A current model for exocyst function proposes 
that a subcomplex of exocyst subunits in S. cerevisiae is carried on 
vesicles to another subcomplex at the plasma membrane, and assem-
bly of these subcomplexes drives vesicle tethering28. However, this 
model has not yet been validated biochemically, nor have the puta-
tive subcomplexes been identified. Whether regulated assembly of 
the exocyst is required for tethering and SNARE-complex regulation 
in yeast or other organisms, and whether these mechanisms differ 
between different species, are important unanswered questions.
Mechanistic models for exocyst function must be informed by 
the structural arrangement of exocyst subunits. Crystal structures of 
several exocyst subunits reveal a strikingly similar motif of contigu-
ous helical bundles that pack together into long rods, thus classifying 
the exocyst within the evolutionarily conserved complexes associ-
ated with tethering containing helical rods (CATCHR) family3,20. 
Numerous pairwise subunit interactions have been identified via 
yeast two-hybrid assays, immunoprecipitations and in vitro binding 
experiments using recombinant and in vitro–translated proteins20,29. 
To examine the architecture and regulation of exocyst assembly, we 
developed a new robust exocyst purification method to reproducibly 
1Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 2Department of 
Biochemistry, University of Utah, Salt Lake City, Utah, USA. 3Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, New York, USA. 
4Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, UK. 5Department of Biochemistry and Biophysics, University of California, San 
Francisco, San Francisco, California, USA. 6Present address: Department of Natural Sciences, Assumption College, Worcester, Massachusetts, USA. Correspondence 
should be addressed to M.M. (mary.munson@umassmed.edu).
Received 15 May; accepted 19 November; published online 14 December 2015; doi:10.1038/nsmb.3146
Subunit connectivity, assembly determinants and 
architecture of the yeast exocyst complex
Margaret R Heider1, Mingyu Gu2, Caroline M Duffy1, Anne M Mirza1, Laura L Marcotte1,6, Alexandra C Walls1, 
Nicholas Farrall2, Zhanna Hakhverdyan3, Mark C Field4, Michael P Rout3, Adam Frost2,5 & Mary Munson1
The exocyst is a hetero-octameric complex that has been proposed to serve as the tethering complex for exocytosis, although 
it remains poorly understood at the molecular level. Here, we purified endogenous exocyst complexes from Saccharomyces 
cerevisiae and showed that they are stable and consist of all eight subunits with equal stoichiometry. Using a combination of 
biochemical and auxin induced–degradation experiments in yeast, we mapped the subunit connectivity, identified two stable 
four-subunit modules within the octamer and demonstrated that several known exocyst-binding partners are not necessary for 
exocyst assembly and stability. Furthermore, we visualized the structure of the yeast complex by using negative-stain electron 
microscopy; our results indicate that the exocyst exists predominantly as a stable, octameric complex with an elongated 
architecture that suggests that the subunits are contiguous helical bundles packed together into a bundle of long rods.
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ONLINE  METHODS
Yeast methods. The strains used in this study are listed in Supplementary Table 1. 
Standard methods were used for yeast media and genetic manipulations. Cells 
were grown in YPD medium containing 1% Bacto-yeast extract (Fisher Scientific), 
2% Bacto-peptone (Fisher Scientific), and 2% glucose (Sigma-Aldrich). All protein 
A (PrA) tags were integrated at the genomic loci in haploid yeast strains (BY4741 
or BY4742) by integration of linear PCR products. PrA products were ampli-
fied from a plasmid (pProtAHIS5, M.P.R.’s laboratory) encoding a PreScission 
Protease (PPX) site upstream of the PrA tag and a Schizosaccharomyces pombe 
HIS5 selection marker36. Approximately 60 bp of sequence homologous to the 
5v end of the coding sequence and 60 bp of sequence homologous to the 3v flank-
ing sequence were used for homologous recombination. All exocyst PrA tags 
were added at the C-terminal ends. AID tags (IAA17) and linker were amplified 
from BYP6740 (pMK43, Yeast Genome Resource Center (YGRC), Japan). For 
C-terminal AID-tag strains, tags were added at the genomic locus of the strain 
BY25598 (YGRC), which expresses OsTIR1 under the ADH1 promoter (parent 
w303-1a), with linear PCR products and kanMX selection. N-terminal AID tags 
(SNC2, SEC4, and CDC42 only) were integrated at the genomic locus of BY4742 
with the pRS306 integrating plasmid61. Inserts were amplified by overlap exten-
sion of PCR products to generate a product consisting of ~300 bp of 5v regulatory 
element, AID tag, linker, and sequence matching the 5v end of the gene of interest, 
and this was then inserted into pRS306 through NotI and XhoI restriction sites. 
The plasmids were linearized with restriction enzymes specific to the 5v regula-
tory elements of each gene (SNC2, MluI; SEC4, BsrGI; CDC42, HpaI) before 
yeast transformation. For the AID-Snc2 strain, SNC1 was deleted by replacing 
the genomic locus with the kanMX cassette. Finally, for all N-terminal AID-tag 
strains, the OsTIR1 gene was integrated at the MET15 locus with a URA3 marker 
and an ADH1 promoter. The plasmid BYP6744 (pNHK53, YGRC) was used as 
a template for generating the OsTIR1 PCR product, and sequence homologous 
to the MET15 regulatory elements was added to the ends. For serial-dilution 
growth assays, yeast cells were grown in YPD to an OD of 1.5 and serially diluted 
ten-fold across YPD plates or YPD plates containing the indicated concentrations 
of IAA (VWR). Yeast plates were incubated at 30 °C for 2 d before imaging on 
Fujifilm LAS3000 (GE).
Exocyst protein A purification. Yeast cells (2 L) were grown in YPD at 30 °C to an 
OD of 1.3–1.5. Cells were washed with water, extruded through a syringe as frozen 
noodles into liquid nitrogen, and stored at −80 °C until lysis36. Noodles were lysed 
in a 50-ml stainless steel Komfort jar with stainless-steel ball bearings, prechilled 
in liquid nitrogen with a PM100 machine (Retsch). The resulting yeast powder 
was stored at −80 °C. 150 mg of yeast powder was added to 1.5-ml microcentri-
fuge tubes prechilled in liquid nitrogen. 600 +l of resuspension buffer (50 mM 
HEPES, pH 7.4, and 150 mM NaCl unless noted otherwise in the text, with 1× 
complete Mini EDTA-free protease-inhibitor solution (Roche Life Science)) was 
added to the tube (with buffer composition varying by experiment, as noted in the 
relevant figures) and was then vortexed and pipetted briefly to achieve complete 
resuspension. Spheroplasting and bead-beating lysis were performed as previ-
ously described7 with 50 mM HEPES, pH 7.4, and 300 mM KCl lysis buffer. The 
use of NaCl versus KCl had no effect on exocyst preparations. Tubes were spun 
at 14,000g for 10 min at 4 °C, and the supernatant was added to 5 +l homemade 
rabbit IgG magnetic bead slurry34,36. Binding was carried out for 45 min at 4 °C 
on a nutating platform. The beads were washed in resuspension buffer and eluted 
either in 1× SDS loading buffer or by 1 h treatment with PreScission Protease 
(GE Healthcare) at 4 °C for a native elution. Samples were run on SDS-PAGE and 
stained with Coomassie Blue or Krypton fluorescent protein stain (Thermo Fisher 
Scientific). Western blot analyses were performed with rabbit polyclonal antibodies 
to Sec6, Sec8, Sec10, Exo70, and Exo84 (refs. 7,27). Rabbit polyclonal antibodies 
to Sec3, Sec15, and Sec5, and mouse monoclonal antibodies to Cdc42 and 
Sec4 were gifts from P. Brennwald (University of North Carolina, Chapel Hill). 
Rabbit polyclonal antibodies to Sec1 and Snc were gifts from C. Carr (Texas 
A&M University). Goat polyclonal antibody to Myo2 was a gift from L. Weisman 
(University of Michigan). Rabbit polyclonal antibody to ADH was purchased 
from Abcam (ab20994). Mouse monoclonal antibody to GFP was purchased 
from Clontech (632380). Western blot analyses of exocyst protein levels in input 
versus unbound samples showed that ~60% of exocyst complexes were bound to 
the beads (varying slightly by bead preparation). The IgG beads were saturated 
in these experiments, however, because the exocyst complexes remaining in the 
lysates could be pulled down by sequential bead incubations. Krypton staining of 
the resulting gels showed no differences in stoichiometry in sequential pulldowns 
of either Sec5-PrA or Sec15-PrA. Coomassie-stained gels were imaged on an LAS 
4000 (GE Healthcare Life Sciences), and Krypton gels were imaged on a Typhoon 
FLA9000 (GE Healthcare Life Sciences). Western blots were treated with ECL 
and imaged on an LAS 4000. Full-size gels and western blots are available in 
Supplementary Data Set 1.
Auxin-induced degradation of exocyst subunits and exocyst regulators. Yeast 
cells (2 L) were grown in YPD at 30 °C to an OD of 1.0. IAA (VWR), dissolved in 
100% ethanol at 500 mM, was added to yeast cultures for a final concentration of 
0.7 mM. The cells were allowed to grow in IAA for 45 min (with 15 min for post-
processing) at 30 °C until an OD of about 1.5 was reached. The cells were then 
washed with water, harvested as frozen noodles, and lysed as described above in 
the purification section. NaOH/SDS lysis was used for visualizing IAA-induced 
degradation in yeast lysates for Figure 3c and Supplementary Figure 3. Briefly, 
2.5 OD units of yeast was incubated in 100 mM NaOH for 5 min, centrifuged to 
remove the NaOH, resuspended in SDS loading buffer with DTT, and heated at 
95 °C before loading onto gels for SDS-PAGE and western blotting.
Bgl2 secretion assay. AID strains were grown at 30 °C in YPD and treated for 
1 h with 0.7 mM IAA before harvesting. Bgl2 secretion assays were performed as 
described in Adamo et al.62. Internal Bgl2 levels were quantified by western blot-
ting and normalized to internal ADH levels. All strains were normalized relative 
to internal Bgl2 levels of the appropriate untreated wild-type-strain control.
Thin-section electron microscopy.  EM on wild-type and AID-tagged yeast 
strains was performed as previously described63. Briefly, yeast cells were grown 
in YPD at 30 °C and treated with 0.7 mM IAA for 1 h. 10 OD units were harvested, 
fixed for 1 h at room temperature with 3% glutaraldehyde, 2.5% sucrose, 5 mM 
CaCl2, and 5 mM MgCl in 0.1 M sodium cacodylate, pH 7.4. Cells were sphero-
plasted with buffer containing 10% `-glucuronidase and 0.5 mg/ml zymolyase 
for 30 min at 30 °C, washed in 0.1 M cacodylate/1 M sorbitol, resuspended in 
0.1 M sodium cacodylate, pH 6.8/1 M sorbitol, and embedded in 2% agarose. 
Agarose pieces were stained with 1% OsO4 and 1% potassium ferrocyanide in 
0.1 M sodium cacodylate, pH 6.8, for 30 min, then washed completely and stained 
in 1% thiocarbohydrazide for 5 min at room temperature. After being washed 
completely, samples were treated for 5 min with 1% OsO4/1% potassium ferro-
cyanide and washed again. After ethanol dehydration and embedding in Epon 
resin (Electron Microscopy Science), thin sections were cut at 70 nm and added 
to uncoated copper grids. Grids were post-stained with uranyl acetate and lead 
citrate. Samples were viewed on a Philips CM10 at 80 kV and recorded with a 
Gatan Erlangshen 785 CCD digital camera.
Negative-stain electron microscopy and image analysis. Sec15-PrA and Sec15-
GFP–Sec6-PrA complexes were purified in 20 mM PIPES, pH 6.8, and 300 mM 
KCl. The complexes were released from IgG beads after PPX cleavage to produce 
purified wild-type and Sec15-GFP complexes. Those complexes were absorbed to 
glow-discharged carbon-coated copper grids and stained with 1% uranyl acetate. 
Micrographs of wild-type complex were collected on an FEI Tecnai F20 elec-
tron microscope operated at 200 kV and 20,400× nominal magnification. The 
defocus value ranged from 0.5 to 2.0 +m. Images were collected with a Gatan 
K2 summit direct detector with final pixel size of 2.45 Å. We semiautomatically 
picked 67,509 Sec15-GFP particles and 24,891 wild-type particles, and performed 
grayscale normalization with Relion-1.3 (ref. 64). Micrographs of the Sec15-GFP 
complex were collected on an FEI Titan Krios electron microscope operated 
at 300 kV and 29,000× nominal magnification. The defocus value ranged from 
0.5 to 3.0 +m. Images were collected automatically with EPU (FEI) with final 
pixel size of 2.87 Å. Particles were selected manually and grayscale normalized 
with BOXER as implemented in EMAN2 (ref. 65). For the Sec15-GFP data set, 
there were 2,568 unique micrographs and 67,509 particles picked; 60,751 particles 
survived. For the untagged wild-type data set, there were 298 unique micrographs 
and 24,891 particles picked; 17,420 particles survived. Contrast transfer function 
(CTF) estimation was performed with CTFFIND3 (ref. 66). CTF correction, 
2D classification and averaging were performed via Maximum a posteriori 
refinement as implemented in RELION64. The negative-stain EM data are  
available upon request.
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